<!DOCTYPE html>
<html lang="en" dir="ltr" 
  xmlns="http://www.w3.org/1999/xhtml"
  xmlns:mml="http://www.w3.org/1998/Math/MathML">
  <head prefix="og: http://ogp.me/ns# article: http://ogp.me/ns/article# book: http://ogp.me/ns/book#" >
    <!--[if IE]><![endif]-->
<link rel="dns-prefetch" href="//d33xdlntwy0kbs.cloudfront.net" />
<link rel="dns-prefetch" href="//www.google.com" />
<link rel="dns-prefetch" href="//scholar.google.com" />
<link rel="dns-prefetch" href="//www.google-analytics.com" />
<link rel="dns-prefetch" href="//stats.g.doubleclick.net" />
<meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
<meta name="viewport" content="width=device-width, initial-scale=1" />
<link rel="shortcut icon" href="https://www.medrxiv.org/sites/default/files/images/favicon.ico" type="image/vnd.microsoft.icon" />
<link rel="alternate" type="application/pdf" title="Full Text (PDF)" href="/content/10.1101/2020.01.08.20016915v1.full.pdf" />
<link rel="alternate" type="text/plain" title="Full Text (Plain)" href="/content/10.1101/2020.01.08.20016915v1.full.txt" />
<link rel="alternate" type="application/vnd.ms-powerpoint" title="Powerpoint" href="/content/10.1101/2020.01.08.20016915v1.ppt" />
<meta name="type" content="article" />
<meta name="category" content="article" />
<meta name="HW.identifier" content="/medrxiv/early/2020/01/10/2020.01.08.20016915.atom" />
<meta name="HW.pisa" content="medrxiv;2020.01.08.20016915v1" />
<meta name="DC.Format" content="text/html" />
<meta name="DC.Language" content="en" />
<meta name="DC.Title" content="Efficacy and Safety of PD-1/PD-L1 plus CTLA-4 antibodies +/− Other Therapies in Lung Cancer: A Systematic Review and Meta-Analysis" />
<meta name="DC.Identifier" content="10.1101/2020.01.08.20016915" />
<meta name="DC.Date" content="2020-01-10" />
<meta name="DC.Publisher" content="Cold Spring Harbor Laboratory Press" />
<meta name="DC.Rights" content="© 2020, Posted by Cold Spring Harbor Laboratory. This pre-print is available under a Creative Commons License (Attribution-NonCommercial-NoDerivs 4.0 International), CC BY-NC-ND 4.0, as described at http://creativecommons.org/licenses/by-nc-nd/4.0/" />
<meta name="DC.AccessRights" content="restricted" />
<meta name="DC.Description" content="Background Immune checkpoint inhibitors have brought hope for patients with advanced lung cancer, among which PD-1/PD-L1 and CTLA-4 inhibitors have achieved considerable results. This meta-analysis aims to investigate the efficacy and safety of PD-1/PD-L1 combined with CTLA-4 antibodies in patients with advanced lung cancer.

Materials and Methods Randomized controlled trials (RCTs) study of PD-1/PD-L1 combined with CTLA-4 inhibitors for advanced lung cancer was searched in the database for systematic review and meta-analysis.

Results The meta-analysis finally included 4 trials (actually 3 trials), and the results showed that the overall response rate of PD-1/PD-L1 combined with CTLA-4 inhibitor was higher than that of the control group (ORR = 2.29 [95% CI 1.58 3.32], P &lt;0.0001). PFS significantly improved compared with conventional treatment (HR = 0.69 [95% CI 0.56, 0.85], P = 0.0005), which was statistically significant. OS also improved but did not statistically significant (HR = 0.80 [95% CI 0.61, 1.05], P = 0.11). PD-1/PD-L1 combined with CTLA-4 inhibitors had a higher incidence of adverse reactions than conventional treatment (OR = 1.72 [95% CI 0.59, 5.09], P = 0.33), but the incidence of grade≥3 AEs was lower than the control group (OR = 0.96 [95% CI 0.64, 1.44], P = 0.85).

Conclusion Double checkpoint inhibitor PD-1/PD-L1 combined with CTLA-4 antibody has synergistic anti-cancer activity and improved ORR and PFS in lung cancer. Adverse reactions are more common than conventional treatment, but are generally controllable. Therefore, PD-1/PD-L1 combined with CTLA-4 inhibitors provides a beacon for the treatment of advanced lung cancer, which has guiding significance for the treatment selection in the future.

### Competing Interest Statement

The authors have declared no competing interest.

### Funding Statement

This research received no specific grant from any funding agency in the public, commercial or not-for-profit sectors.

### Author Declarations

All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.

Yes

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

No data are available." />
<meta name="DC.Contributor" content="Xiang Shen" />
<meta name="DC.Contributor" content="Hua Xiao" />
<meta name="DC.Contributor" content="Shangke Huang" />
<meta name="DC.Contributor" content="Jiexing Liu" />
<meta name="DC.Contributor" content="Zhuolan Ran" />
<meta name="DC.Contributor" content="Bin Xiong" />
<meta name="article:published_time" content="2020-01-10" />
<meta name="citation_title" content="Efficacy and Safety of PD-1/PD-L1 plus CTLA-4 antibodies +/− Other Therapies in Lung Cancer: A Systematic Review and Meta-Analysis" />
<meta name="citation_abstract" lang="en" content="&lt;h3&gt;ABSTRACT&lt;/h3&gt;
&lt;h3&gt;Background&lt;/h3&gt;
&lt;p&gt;Immune checkpoint inhibitors have brought hope for patients with advanced lung cancer, among which PD-1/PD-L1 and CTLA-4 inhibitors have achieved considerable results. This meta-analysis aims to investigate the efficacy and safety of PD-1/PD-L1 combined with CTLA-4 antibodies in patients with advanced lung cancer.&lt;/p&gt;&lt;h3&gt;Materials and Methods&lt;/h3&gt;
&lt;p&gt;Randomized controlled trials (RCTs) study of PD-1/PD-L1 combined with CTLA-4 inhibitors for advanced lung cancer was searched in the database for systematic review and meta-analysis.&lt;/p&gt;&lt;h3&gt;Results&lt;/h3&gt;
&lt;p&gt;The meta-analysis finally included 4 trials (actually 3 trials), and the results showed that the overall response rate of PD-1/PD-L1 combined with CTLA-4 inhibitor was higher than that of the control group (ORR = 2.29 [95% CI 1.58 3.32], P &amp;lt;0.0001). PFS significantly improved compared with conventional treatment (HR = 0.69 [95% CI 0.56, 0.85], P = 0.0005), which was statistically significant. OS also improved but did not statistically significant (HR = 0.80 [95% CI 0.61, 1.05], P = 0.11). PD-1/PD-L1 combined with CTLA-4 inhibitors had a higher incidence of adverse reactions than conventional treatment (OR = 1.72 [95% CI 0.59, 5.09], P = 0.33), but the incidence of grade≥3 AEs was lower than the control group (OR = 0.96 [95% CI 0.64, 1.44], P = 0.85).&lt;/p&gt;&lt;h3&gt;Conclusion&lt;/h3&gt;
&lt;p&gt;Double checkpoint inhibitor PD-1/PD-L1 combined with CTLA-4 antibody has synergistic anti-cancer activity and improved ORR and PFS in lung cancer. Adverse reactions are more common than conventional treatment, but are generally controllable. Therefore, PD-1/PD-L1 combined with CTLA-4 inhibitors provides a beacon for the treatment of advanced lung cancer, which has guiding significance for the treatment selection in the future.&lt;/p&gt;" />
<meta name="citation_journal_title" content="medRxiv" />
<meta name="citation_publisher" content="Cold Spring Harbor Laboratory Press" />
<meta name="citation_publication_date" content="2020/01/01" />
<meta name="citation_mjid" content="medrxiv;2020.01.08.20016915v1" />
<meta name="citation_id" content="2020.01.08.20016915v1" />
<meta name="citation_public_url" content="https://www.medrxiv.org/content/10.1101/2020.01.08.20016915v1" />
<meta name="citation_abstract_html_url" content="https://www.medrxiv.org/content/10.1101/2020.01.08.20016915v1.abstract" />
<meta name="citation_full_html_url" content="https://www.medrxiv.org/content/10.1101/2020.01.08.20016915v1.full" />
<meta name="citation_pdf_url" content="https://www.medrxiv.org/content/medrxiv/early/2020/01/10/2020.01.08.20016915.full.pdf" />
<meta name="citation_doi" content="10.1101/2020.01.08.20016915" />
<meta name="citation_num_pages" content="28" />
<meta name="citation_article_type" content="Article" />
<meta name="citation_firstpage" content="2020.01.08.20016915" />
<meta name="citation_author" content="Xiang Shen" />
<meta name="citation_author_institution" content="Department of Respiratory Medicine, The Affiliated Hospital of Southwest Medical University" />
<meta name="citation_author" content="Hua Xiao" />
<meta name="citation_author_institution" content="Department of Respiratory Medicine, The Affiliated Hospital of Southwest Medical University" />
<meta name="citation_author" content="Shangke Huang" />
<meta name="citation_author_institution" content="Oncology Department, The Affiliated Hospital of Southwest Medical University" />
<meta name="citation_author" content="Jiexing Liu" />
<meta name="citation_author_institution" content="Department of Respiratory Medicine, The Affiliated Hospital of Southwest Medical University" />
<meta name="citation_author" content="Zhuolan Ran" />
<meta name="citation_author_institution" content="Department of Respiratory Medicine, The Affiliated Hospital of Southwest Medical University" />
<meta name="citation_author" content="Bin Xiong" />
<meta name="citation_author_institution" content="Department of Respiratory Medicine, The Affiliated Hospital of Southwest Medical University" />
<meta name="citation_author_email" content="xionbin321@163.com" />
<meta name="citation_reference" content="Jiemin M, Ahmedin J, Stacey AF, et al. The American Cancer Society 2035 challenge goal on cancer mortality reduction. CA Cancer J Clin 2019;69:351–62 doi:10.3322/caac.21564 [Published Online First: 08 May 2019]." />
<meta name="citation_reference" content="Miller KD, Nogueira L, Mariotto AB, et al. Cancer treatment and survivorship statistics, 2019. CA Cancer J Clin 2019;69:363–85 doi:10.3322/caac.21565 [Published Online First: 11 June 2019]." />
<meta name="citation_reference" content="Palakurthi S, Kuraguchi M, Zacharek SJ, et al. The combined effect of FGFR inhibition and PD-1 blockade promotes tumor-intrinsic induction of antitumor immunity. Cancer Immunol Res 2019;7:1457–71 doi:10.1158/2326-6066.cir-18-0595." />
<meta name="citation_reference" content="Girard N. Optimizing outcomes in EGFR mutation-positive NSCLC: which tyrosine kinase inhibitor and when? Future Oncol Published Online First: 16 Jan 2018 doi:10.2217/fon-2017-0636." />
<meta name="citation_reference" content="Morris TA, Khoo C, Solomon BJ. Targeting ROS1 Rearrangements in Non-small Cell Lung Cancer: Crizotinib and Newer Generation Tyrosine Kinase Inhibitors. Drugs 2019;79:1277–86 doi:10.1007/s40265-019-01164-3 [Published Online First: 16 July 2019]." />
<meta name="citation_reference" content="Najafi M, Farhood B, Mortezaee K. Contribution of regulatory T cells to cancer: a review. J Cell Physiol 2019;234:7983–7993 doi:10.1002/jcp.27553 [Published Online First: 14 Oct 2018]." />
<meta name="citation_reference" content="Vinay DS, Ryan EP, Pawelec G, et al. Immune evasion in cancer: mechanistic basis and therapeutic strategies. Semin Cancer Biol 2015;35(Suppl):S185–98 doi:10.1016/j.semcancer.2015.03.004." />
<meta name="citation_reference" content="Schumacher TN, Schreiber RD. Neoantigens in cancer immunotherapy. Science 2015;348:69–74 doi:10.1126/science.aaa4971 [Published Online First: 03 Apr 2015]." />
<meta name="citation_reference" content="Barber D.L, Wherry E.J, Masopust D, et al. Restoring function in exhausted CD8 T cells during chronic viral infection. Nature 2006;439:682–7 doi:10.1038/nature04444 [Published Online First: 28 Dec 2015]." />
<meta name="citation_reference" content="Topalian SL, Drake CG, Pardoll DM. Immune checkpoint blockade: a common denominator approach to cancer therapy. Cancer Cell 2015;27:450–61 doi:10.1016/j.ccell.2015.03.001." />
<meta name="citation_reference" content="Paulsen EE, Kilvaer TK, Rakaee M, et al. CTLA-4 expression in the non-small cell lung cancer patient tumor microenvironment: diverging prognostic impact in primary tumors and lymph node metastases. Cancer Immunol Immunother 2017;66:1449–61 doi:10.1007/s00262-017-2039-2." />
<meta name="citation_reference" content="Kim DH, Kim H, Choi YJ, et al. Exosomal PD-L1 promotes tumor growth through immune escape in non-small cell lung cancer. Exp Mol Med 2019;51:94 doi:10.1038/s12276-019-0295-2 [Published Online First:09 August 2019]." />
<meta name="citation_reference" content="Rittmeyer A, Barlesi F, Waterkamp D, et al. Atezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a phase 3, openlabel, multicentre randomised controlled trial. Lancet 2017;389:255–65 doi:10.1016/s0140-6736(16)32517-x [Published Online First:12 Dec 2016]." />
<meta name="citation_reference" content="Herbst RS, Baas P, Kim DW, et al. Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial. Lancet 2016;387:1540–50 doi:10.1016/s0140-6736(15)01281-7 [Published Online First: 19 Dec 2015]." />
<meta name="citation_reference" content="Planchard D, Popat S, Kerr K, et al. Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2018; 30:863–70 doi:10.1093/annonc/mdy474." />
<meta name="citation_reference" content="Schuler M, Paz-Ares L, Sequist LV, et al. First-line afatinib for advanced EGFRm+ NSCLC: Analysis of long-term responders in the LUX-Lung 3, 6, and 7 trials. Lung Cancer 2019;133:10–19 doi:10.1016/j.lungcan.2019.04.006." />
<meta name="citation_reference" content="Ackermann CJ, Reck M, Paz-Ares L, et al. First-line immune checkpoint blockade for advanced Non-Small-Cell Lung Cancer: travelling at the speed of light. Lung Cancer 2019;134:245–53 doi:10.1016/j.lungcan.2019.06.007" />
<meta name="citation_reference" content="Proto C, Ferrara R, Signorelli D, et al. Choosing wisely first line immunotherapy in non-small cell lung cancer (NSCLC): What to add and what to leave out. Cancer Treat Rev 2019;75:39–51 doi:10.1016/j.ctrv.2019.03.004" />
<meta name="citation_reference" content="Verma V, Sharma G, Singh A. Immunotherapy in extensive small cell lung cancer. Exp Hematol Oncol 2019;8:5 doi:10.1186/s40164-019-0129-x [Published Online First: 04 Fed 2019]." />
<meta name="citation_reference" content="Rizvi NA, Cho BC, Reinmuth N, et al. Durvalumab with or without tremelimumab vs platinum-based chemotherapy as first-line treatment for metastatic non-small cell lung cancer: MYSTIC. Ann Oncol 2018;29(uppl 10):abstract LBA6." />
<meta name="citation_reference" content="Hellmann MD, Rizvi NA, Goldman JW, et al. Nivolumab plus ipilimumab as first-line treatment for advanced non-small-cell lung cancer (CheckMate 012): results of an open-label, phase 1, multicohort study. Lancet Oncol 2017;18:31–41 doi:10.1016/S1470-2045(16)30624-6 [Published Online First: 05 Dec 2016]." />
<meta name="citation_reference" content="Larkin J, Hodi FS, Wolchok JD. Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma. N Engl J Med 2015;373:1270–1 doi:10.1056/nejmc1509660 [Published Online First: 24 Sep 2015]." />
<meta name="citation_reference" content="Postow MA, Sidlow R, Hellmann MD. Immune-related adverse events associated with immune checkpoint blockade. N Engl J Med 2018;378:158–68 doi:10.1056/nejmra1703481 [Published Online First: 11 Jan 2018]." />
<meta name="citation_reference" content="Naqash AR, Appah E,Yang LV, et al. Isolated neutropenia as a rare but serious adverse event secondary to immune checkpoint inhibition. J Immunother Cancer 2019;7:169 doi:10.1186/s40425-019-0648-3 [Published Online First: 05 July 2019]." />
<meta name="citation_reference" content="Alissafi T, Hatzioannou A, Legaki AI, et al. Balancing cancer immunotherapy and immune-related adverse events: The emerging role ofregulatory T cells. J Autoimmun 2019;104:102310 doi:10.1016/j.jaut.2019.102310" />
<meta name="citation_reference" content="Davies M, Duffield EA. Safety of checkpoint inhibitors for cancer treatment: strategies for patient monitoring and management of immune-mediated adverse events. Immunotargets Ther 2017;6:51–71 doi: 10.2147/itt.s141577 [Published Online First:24 Aug 2017]" />
<meta name="citation_reference" content="Brahmer JR, Lacchetti C, Schneider BJ, et al. Management of immune-related adverse events in patients treated with immune checkpoint inhibitor therapy: American Society of Clinical Oncology clinical practice guideline. J Clin Oncol 2018; 36:1714–68 doi:10.1200/jco.2017.77.6385 [Published Online First:14 Feb 2018]." />
<meta name="citation_reference" content="Champiat S, Lambotte O, Barreau E, et al. Management of immune checkpoint blockade dysimmune toxicities: a collaborative position paper. Ann Oncol 2016;27:559–74 doi:10.1093/annonc/mdv623" />
<meta name="citation_reference" content="Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 1996;17:1–12" />
<meta name="citation_reference" content="Kowalski DM, Reinmuth N, Orlov SV, et al. ARCTIC: Durvalumab + tremelimumab and durvalumab monotherapy vs SoC in≥3L advanced NSCLC treatment. Ann Oncol 2018;29(suppl 8):abstract 1378O." />
<meta name="citation_reference" content="Hellmann MD, Ciuleanu TE, Pluzanski A, et al. Nivolumab plus Ipilimumab in Lung Cancer with a High Tumor Mutational Burden. N Engl J Med 2018, 378:2093–04 doi:10.1056/nejmoa1801946 [Published Online First:31 May 2018]." />
<meta name="citation_reference" content="Antonia SJ, López-Martin JA, Bendell J, et al. Nivolumab alone and nivolumab plus ipilimumab in recurrent small-cell lung cancer (CheckMate 032): a multicentre, open-label, phase 1/2 trial. Lancet Oncol 2016;17:883–95 doi:10.1016/S1470-2045(16)30098-5 [Published Online First:04 June 2016]." />
<meta name="citation_reference" content="Herbst RS, Baas P, Kim DW, et al. Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial. Lancet 2016;387:1540–1550 doi:10.1016/S0140-6736(15)01281-7 [Published Online First:19 Dec 2015]." />
<meta name="citation_reference" content="Borghaei H, Paz-Ares L, Horn L, et al. Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer. N Engl J Med 2015;373:1627–1639 doi:10.1056/NEJMoa1507643 [Published Online First:22 Oct 2015]." />
<meta name="citation_reference" content="Paz-Ares L, Dvorkin M, Chen YB, et al. Durvalumab plus platinum-etoposide versus platinum-etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial. Lancet 2019;394:1929–39 doi:10.1016/S0140-6736(19)32222-6 [Published Online First:23 Nov 2019]." />
<meta name="citation_reference" content="Robert L, Tsoi J, Wang X, et al. CTLA4 Blockade Broadens the Peripheral T-Cell Receptor Repertoire. Clin Cancer Res 2014;20: 2424–32 doi:10.1158/1078-0432.ccr-13-2648" />
<meta name="citation_reference" content="Scheper W, Kelderman S, Fanchi LF, et al. Low and variable tumor reactivity of the intratumoral TCR repertoire in human cancers. Nat Med 2018;25:89–94 doi:10.1038/s41591-018-0266-5 [Published Online First:03 Dec 2018]." />
<meta name="citation_reference" content="Li JY, Byrne KT, Yan FX, et al. Tumor Cell-Intrinsic Factors Underlie Heterogeneity of Immune Cell Infiltration and Response to Immunotherapy. Immunity 2018;49:178–193.e7 doi:10.1016/j.immuni.2018.06.006 [Published Online First:26 June 2018]." />
<meta name="citation_reference" content="Chae YK, Arya A, Iams W, et al. Current landscape and future of dual anti-CTLA4 and PD-1/PD-L1 blockade immunotherapy in cancer; lessons learned from clinical trials with melanoma and non-small cell lung cancer (NSCLC). J Immunother Cancer 2018;6:39 doi: 10.1186/s40425-018-0349-3." />
<meta name="citation_reference" content="Tran L, Allen CT, Xiao R, et al. Cisplatin Alters Antitumor Immunity and Synergizes with PD1/PD-L1 Inhibition in Head and Neck Squamous Cell Carcinoma. Cancer Immunol Res 2017;5:1141–51 doi:10.1158/2326-6066.CIR-17-0235" />
<meta name="citation_reference" content="Fournel L, Wu Z, Stadler N, et al. Cisplatin increases PD-L1 expression and optimizes immune check-point blockade in non-small cell lung cancer. Cancer Lett 2019;464:5–14 doi:10.1016/j.canlet.2019.08.005" />
<meta name="citation_reference" content="Remark R, Lupo A, Alifano M, et al. Immune contexture and histological response after neoadjuvant chemotherapy predict clinical outcome of lung cancer patients. Oncoimmunology 2016;5:e1255394 doi:10.1080/2162402X.2016.1255394 [Published Online First:18 Dec 2016]." />
<meta name="citation_reference" content="Durante M, Reppingen N, Held KD. Immunologically augmented cancer treatment using modern radiotherapy. Trends Mol Med 2013;19:565–82 doi:10.1016/j.molmed.2013.05.007 [Published Online First:09 July 2013]." />
<meta name="citation_reference" content="Bos PD, Plitas G, Rudra D, et al. Transient regulatory T cell ablation deters oncogene-driven breast cancer and enhances radiotherapy. J Exp Med 2013;210:2435–66 doi:10.1084/jem.20130762 [Published Online First:14 Oct 2013]." />
<meta name="citation_reference" content="Gupta A, Probst HC, Vuong V, et al. Radiotherapy promotes tumor-specific effector CD8+ T cells via dendritic cell activation. J Immunol 2012;189:558–66. doi:10.4049/jimmunol.1200563 [Published Online First:15 July 2012]" />
<meta name="citation_reference" content="Demaria S, Bhardwaj N, McBride W.H, et al. Combining radiotherapy and immunotherapy: a revived partnership. Int J Radiat Oncol Biol Phys 2005;63:655–66 doi: 10.1016/j.ijrobp.2005.06.032 [Published Online First:01 Nov 2005]" />
<meta name="citation_reference" content="De WK, Vermaelen K, De MG, et al. The potential of radiotherapy to enhance the efficacy of renal cell carcinoma therapy. Oncoimmunology 2015;4:e1042198 doi: 10.1080/2162402X.2015.1042198 [Published Online First:27 May 2015]." />
<meta name="citation_reference" content="Buttigliero C, Allis S, Tucci M, et el. Role of radiotherapy in improving activity of immune-modulating drugs in advanced renal cancer: Biological rationale and clinical evidences. Cancer Treat Rev 2018, 69:215–23 doi:10.1016/j.ctrv.2018.07.010" />
<meta name="citation_reference" content="Ready N, Hellmann MD, Awad MM, et al. First-Line Nivolumab Plus Ipilimumab in Advanced Non–Small-Cell Lung Cancer (CheckMate 568): Outcomes by Programmed Death Ligand 1 and Tumor Mutational Burden as Biomarkers. J Clin Oncol 2019;37:992–1000 doi:10.1200/JCO.18.01042 [Published Online First:20 Feb 2019]." />
<meta name="citation_reference" content="Yu H, Boyle TA, Zhou C, et al. PD-L1 Expression in Lung Cancer. J Thorac Oncol 2016;11:964–975 doi:10.1016/j.jtho.2016.04.014" />
<meta name="citation_reference" content="Chan TA, Yarchoan M, Jaffee E, et al. Development of Tumor Mutation Burden as an Immunotherapy Biomarker: Utility for the Oncology Clinic. Ann Oncol 2018;30:44–56 doi:10.1093/annonc/mdy495 [Published Online First:05 Nov 2018]." />
<meta name="citation_reference" content="Hugo W, Zaretsky JM, Sun L, et al. Genomic and Transcriptomic Features of Response to Anti-PD-1 Therapy in Metastatic Melanoma. Cell 2016;165:35–44 doi:10.1016/j.cell.2016.02.065 [Published Online First:24 Mar 2016]." />
<meta name="citation_reference" content="Hellmann MD, Nathanson T, Rizvi H, et al. Genomic Features of Response to Combination Immunotherapy in Patients with Advanced Non-Small-Cell Lung Cancer. Cancer Cell 2018;33:843-852.e4 doi:10.1016/j.ccell.2018.03.018 [Published Online First:12 Apr 2018]." />
<meta name="citation_reference" content="Riaz N, Morris L, Havel JJ, et al. The role of neoantigens in response to immune checkpoint blockade. Int Immunol 2016;28:411–9 doi:10.1093/intimm/dxw019." />
<meta name="citation_reference" content="Forschner A, Battke F, Hadaschik D, et al. Tumor mutation burden and circulating tumor DNA in combined CTLA-4 and PD-1 antibody therapy in metastatic melanoma – results of a prospective biomarker study. J Immunother Cancer 2019;7:180 doi:10.1186/s40425-019-0659-0 [Published Online First: 12 July 2019]." />
<meta name="citation_reference" content="Hellmann MD, Margaret KC, Mark MA, et al. Tumor Mutational Burden and Efficacy of Nivolumab Monotherapy and in Combination with Ipilimumab in Small-Cell Lung Cancer. Cancer Cell 2018;33:853 doi:10.1016/j.ccell.2018.04.001 [Published Online First:14 May 2018]." />
<meta name="citation_reference" content="Eggermont AM, Chiarion-Sileni V, Grob JJ, et al. Prolonged survival in stage III melanoma with ipilimumab adjuvant therapy. N Engl J Med 2016;375:1845–55 : doi:10.1056/NEJMoa1611299 [Published Online First:10 Nov 2016]." />
<meta name="citation_reference" content="Martins F, Sofiya L, Sykiotis GP, et al. Adverse effects of immune-checkpoint inhibitors:epidemiology,management and surveillance. Nat Rev Clin Oncol 2019;16:563–80 doi:10.1038/s41571-019-0218-0 [Published Online First:15 May 2019]." />
<meta name="citation_reference" content="Buckley LM, Suarez-Almazor ME. Is Immune Check Point Inhibitor Treatment an Option for Patients with Rheumatic Diseases and Cancer? Arthritis Rheumatol 2019;71:1971–73 doi:10.1002/art.41064" />
<meta name="citation_reference" content="Postow MA, Chesney J, Pavlick AC, et al. Nivolumab and ipilimumab versus ipilimumab in untreated melanoma. N Engl J Med 2015;372:2006–17 doi: 10.1056/NEJMoa1414428 [Published Online First:]" />
<meta name="citation_reference" content="Bomze D, Hasan Ali O, Bate A, et al. Association Between Immune-Related Adverse Events During Anti-PD-1 Therapy and Tumor Mutational Burden. JAMA Oncol 2019;5:1633–1635 doi:10.1001/jamaoncol.2019.3221 22 [Published Online First:Aug 2019]." />
<meta name="citation_reference" content="Uemura M, Trinh VA, Haymaker C, et al. Selective inhibition of autoimmune exacerbation while preserving the anti-tumor clinical benefit using IL-6 blockade in a patient with advanced melanoma and Crohn’s disease: a case report. J Hematol Oncol 2016;9:81 doi:10.1186/s13045-016-0309-7" />
<meta name="citation_reference" content="Iivanainen S, Koivunen JP. Early PD-1 Therapy Discontinuation in Responding Metastatic Cancer Patients. Oncology Published Online First:31 Oct 2018 doi: 10.1159/000493193." />
<meta name="citation_reference" content="Wang DY, Salem JE, Cohen JV, et al. Fatal Toxic Effects Associated With Immune Checkpoint Inhibitors: A Systematic Review and Meta-analysis. JAMA Oncol 2018;4:1721–8 doi:10.1001/jamaoncol.2018.3923 [Published Online First:13 Sep 2018]" />
<meta name="citation_reference" content="Haanen JBAG, Carbonnel F, Robert C, et al. Management of toxicities from immunotherapy: ESMO clinical practice guidelines for diagnosis, treatment and followup. Ann Oncol 2018;29(uppl 4): iv264–iv266 doi:10.1093/annonc/mdy162." />
<meta name="citation_reference" content="Perez BA, Kim S, Dilling TJ, et al. A Prospective Single Arm Phase I/II Study: Consolidative Ipilimumab and Nivolumab with Thoracic Radiotherapy after Platinum Based Chemotherapy for Patients with Extensive-Stage Small Cell Lung. Int J Radiat Oncol Biol Phys 2019;105: S36 doi:10.1016/j.ijrobp.2019.06.452 [Published Online First:1 sep 2019]." />
<meta name="citation_reference" content="Von Pawel J, Fischer J, Alt J, et al. MYSTIC - A Phase III, randomized, open-label study of Durvalumab (MEDI4736) in combination with Tremelimumab or Durvalumab alone versus platinum-based chemotherapy in first-line treatment of patients with advanced stage IV non small cell lung cancer (aNSCLC): A German update. Oncol Res Treat 2016;39:87." />
<meta name="citation_reference" content="Senan S, Shire N, Mak G, et al. ADRIATIC: A phase III trial of durvalumab 6 tremelimumab after concurrent chemoradiation for patients with limited stage small cell lung cancer. Ann Oncol 2019;30:25." />
<meta name="citation_reference" content="Mok T, Schmid P, De Castro G, et al. First-line durvalumab plus tremelimumab vs platinum-based chemotherapy for advanced/metastatic NSCLC: Phase 3 NEPTUNE Study. J Thorac Oncol 2017;12:S1084." />
<meta name="citation_reference" content="Thomas M, Grohe C, Eberhardt W, et al. POSEIDON: A phase 3 study of first-line Durvalumab ± Tremelimumab + chemotherapy vs chemotherapy alone in metastatic NSCLC. Oncol Res Treat 2018;41:295." />
<meta name="citation_reference" content="Paz-Ares L, Jiang H, Huang Y, et al. Caspian: Phase 3 study of first-line durvalumab ± tremelimumab + platinum-based chemotherapy vs chemotherapy alone in ED-SCLC. J Thorac Oncol 2017;12:S2398." />
<meta name="citation_reference" content="Paz-Ares L, Brahmer J, Hellmann MD. CheckMate 227: A randomized, open-label phase 3 trial of nivolumab nivolumab plus ipilimumab, or nivolumab plus chemotherapy versus chemotherapy in chemotherapy-naïve patients with advanced non-small cell lung cancer (NSCLC). Ann Oncol 2017;28." />
<meta name="citation_reference" content="Felip E, Brahmer J, Broderick S, et al. CheckMate 816: A Phase 3 Trial of Neoadjuvant Nivolumab Plus Ipilimumab or Chemotherapy vs Chemotherapy in Early-Stage NSCLC. J Thorac Oncol 2018;13:S831–S832 doi:10.1016/j.jtho.2018.08.1478" />
<meta name="citation_reference" content="Boyer M, McLean J, Xu L, et al. Pembrolizumab Plus Ipilimumab or Placebo in 1L Metastatic NSCLC with PD-L1 Tumor Proportion Score (TPS) ≥50%: KEYNOTE-598. J Thorac Oncol 2018;13:S462 doi:10.1016/j.jtho.2018.08.565." />
<meta name="twitter:title" content="Efficacy and Safety of PD-1/PD-L1 plus CTLA-4 antibodies +/− Other Therapies in Lung Cancer: A Systematic Review and Meta-Analysis" />
<meta name="twitter:site" content="@medrxivpreprint" />
<meta name="twitter:card" content="summary" />
<meta name="twitter:description" content="Background Immune checkpoint inhibitors have brought hope for patients with advanced lung cancer, among which PD-1/PD-L1 and CTLA-4 inhibitors have achieved considerable results. This meta-analysis aims to investigate the efficacy and safety of PD-1/PD-L1 combined with CTLA-4 antibodies in patients with advanced lung cancer.

Materials and Methods Randomized controlled trials (RCTs) study of PD-1/PD-L1 combined with CTLA-4 inhibitors for advanced lung cancer was searched in the database for systematic review and meta-analysis.

Results The meta-analysis finally included 4 trials (actually 3 trials), and the results showed that the overall response rate of PD-1/PD-L1 combined with CTLA-4 inhibitor was higher than that of the control group (ORR = 2.29 [95% CI 1.58 3.32], P &lt;0.0001). PFS significantly improved compared with conventional treatment (HR = 0.69 [95% CI 0.56, 0.85], P = 0.0005), which was statistically significant. OS also improved but did not statistically significant (HR = 0.80 [95% CI 0.61, 1.05], P = 0.11). PD-1/PD-L1 combined with CTLA-4 inhibitors had a higher incidence of adverse reactions than conventional treatment (OR = 1.72 [95% CI 0.59, 5.09], P = 0.33), but the incidence of grade≥3 AEs was lower than the control group (OR = 0.96 [95% CI 0.64, 1.44], P = 0.85).

Conclusion Double checkpoint inhibitor PD-1/PD-L1 combined with CTLA-4 antibody has synergistic anti-cancer activity and improved ORR and PFS in lung cancer. Adverse reactions are more common than conventional treatment, but are generally controllable. Therefore, PD-1/PD-L1 combined with CTLA-4 inhibitors provides a beacon for the treatment of advanced lung cancer, which has guiding significance for the treatment selection in the future.

### Competing Interest Statement

The authors have declared no competing interest.

### Funding Statement

This research received no specific grant from any funding agency in the public, commercial or not-for-profit sectors.

### Author Declarations

All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.

Yes

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

No data are available." />
<meta name="og-title" property="og:title" content="Efficacy and Safety of PD-1/PD-L1 plus CTLA-4 antibodies +/− Other Therapies in Lung Cancer: A Systematic Review and Meta-Analysis" />
<meta name="og-url" property="og:url" content="https://www.medrxiv.org/content/10.1101/2020.01.08.20016915v1" />
<meta name="og-site-name" property="og:site_name" content="medRxiv" />
<meta name="og-description" property="og:description" content="Background Immune checkpoint inhibitors have brought hope for patients with advanced lung cancer, among which PD-1/PD-L1 and CTLA-4 inhibitors have achieved considerable results. This meta-analysis aims to investigate the efficacy and safety of PD-1/PD-L1 combined with CTLA-4 antibodies in patients with advanced lung cancer.

Materials and Methods Randomized controlled trials (RCTs) study of PD-1/PD-L1 combined with CTLA-4 inhibitors for advanced lung cancer was searched in the database for systematic review and meta-analysis.

Results The meta-analysis finally included 4 trials (actually 3 trials), and the results showed that the overall response rate of PD-1/PD-L1 combined with CTLA-4 inhibitor was higher than that of the control group (ORR = 2.29 [95% CI 1.58 3.32], P &lt;0.0001). PFS significantly improved compared with conventional treatment (HR = 0.69 [95% CI 0.56, 0.85], P = 0.0005), which was statistically significant. OS also improved but did not statistically significant (HR = 0.80 [95% CI 0.61, 1.05], P = 0.11). PD-1/PD-L1 combined with CTLA-4 inhibitors had a higher incidence of adverse reactions than conventional treatment (OR = 1.72 [95% CI 0.59, 5.09], P = 0.33), but the incidence of grade≥3 AEs was lower than the control group (OR = 0.96 [95% CI 0.64, 1.44], P = 0.85).

Conclusion Double checkpoint inhibitor PD-1/PD-L1 combined with CTLA-4 antibody has synergistic anti-cancer activity and improved ORR and PFS in lung cancer. Adverse reactions are more common than conventional treatment, but are generally controllable. Therefore, PD-1/PD-L1 combined with CTLA-4 inhibitors provides a beacon for the treatment of advanced lung cancer, which has guiding significance for the treatment selection in the future.

### Competing Interest Statement

The authors have declared no competing interest.

### Funding Statement

This research received no specific grant from any funding agency in the public, commercial or not-for-profit sectors.

### Author Declarations

All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.

Yes

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

No data are available." />
<meta name="og-type" property="og:type" content="article" />
<meta name="og-image" property="og:image" content="" />
<meta name="citation_date" content="2020-01-10" />
<meta name="description" content="medRxiv - The Preprint Server for Health Sciences" />
<meta name="generator" content="Drupal 7 (http://drupal.org)" />
<link rel="canonical" href="https://www.medrxiv.org/content/10.1101/2020.01.08.20016915v1" />
<link rel="shortlink" href="https://www.medrxiv.org/node/71120" />
    <title>Efficacy and Safety of PD-1/PD-L1 plus CTLA-4 antibodies +/− Other Therapies in Lung Cancer: A Systematic Review and Meta-Analysis | medRxiv</title>  
    <link type="text/css" rel="stylesheet" href="https://www.medrxiv.org/sites/default/files/advagg_css/css__7SC0i-kTgUlQGKuqbmyS18Sez8FDO-aG9FSHkGrLGl8__9Xf-fJpmF9h8tvWywQTaOzJzFLt4sEfx108Wh1gYmm0__OWu9jWxbqz5eMqeTDc4xZhOzPlgoEqGh5PmxOqlf8ZY.css" media="all" />
<link type="text/css" rel="stylesheet" href="//cdn.jsdelivr.net/qtip2/2.2.1/jquery.qtip.min.css" media="all" />
<link type="text/css" rel="stylesheet" href="https://www.medrxiv.org/sites/default/files/advagg_css/css__QLVgjdRXCWGirSa_x5mquqUl-8pWzM9iC9MQ8XsESGg__amqgNDRnD7kYkhajPuQ6deCUzX5nPy20dYM5wTYb6ZQ__OWu9jWxbqz5eMqeTDc4xZhOzPlgoEqGh5PmxOqlf8ZY.css" media="all" />
<style type="text/css" media="all">
/* <![CDATA[ */
#sliding-popup.sliding-popup-bottom,#sliding-popup.sliding-popup-bottom .eu-cookie-withdraw-banner,.eu-cookie-withdraw-tab{background:gray}#sliding-popup.sliding-popup-bottom.eu-cookie-withdraw-wrapper{background:transparent}#sliding-popup .popup-content #popup-text h1,#sliding-popup .popup-content #popup-text h2,#sliding-popup .popup-content #popup-text h3,#sliding-popup .popup-content #popup-text p,.eu-cookie-compliance-secondary-button,.eu-cookie-withdraw-tab{color:#fff !important}.eu-cookie-withdraw-tab{border-color:#fff}.eu-cookie-compliance-more-button{color:#fff !important}
/* ]]> */
</style>

<!--[if lte IE 7]>
<link type="text/css" rel="stylesheet" href="https://www.medrxiv.org/sites/default/files/advagg_css/css__ElJr3PIJEvw3qLXc1cnYiLj2G4KgDPSXFOfm6Phf8hw__JdWGm15cDWjsK6KrFlQVXQix9YgNeYysf22XZHj-Y-c__OWu9jWxbqz5eMqeTDc4xZhOzPlgoEqGh5PmxOqlf8ZY.css" media="all" />
<![endif]-->
<link type="text/css" rel="stylesheet" href="https://www.medrxiv.org/sites/default/files/advagg_css/css__Wnlyen9qEpwh_Qaf9okEu4QdVGM0BDothxeqA6Nbvo8__EJmw6SZD9bYoS8jocCpPYS3JFRURpdzmuvJoAUNiI-g__OWu9jWxbqz5eMqeTDc4xZhOzPlgoEqGh5PmxOqlf8ZY.css" media="all" />
<link type="text/css" rel="stylesheet" href="https://www.medrxiv.org/sites/default/files/advagg_css/css__XPg6Aobs217v0T9rA_Y-wMrH3jyqmqunImGwMN4WMEE__Nc8_6i0mjd_g-hzHvpxLmo5g2aluEkJf5SXcEKb7YRY__OWu9jWxbqz5eMqeTDc4xZhOzPlgoEqGh5PmxOqlf8ZY.css" media="all" />

<!--[if (lt IE 9)&(!IEMobile)]>
<link type="text/css" rel="stylesheet" href="https://www.medrxiv.org/sites/default/files/advagg_css/css__XH6bpcI0f2dImc-p674DLCZtWBGb-QwxJK1YexVGtno__vUceGprdo5nIhV6DH93X7fI3r8RcTJbChbas9TQXeW4__OWu9jWxbqz5eMqeTDc4xZhOzPlgoEqGh5PmxOqlf8ZY.css" media="all" />
<![endif]-->

<!--[if gte IE 9]><!-->
<link type="text/css" rel="stylesheet" href="https://www.medrxiv.org/sites/default/files/advagg_css/css__2WBMox6sOrN42ss5lCnH7WWVRdFdJCxtTKnQJYRwTE4__yqNvNYLvMpjy3ffuJrjjm9uW2i-Me1c23KLYuWHaqio__OWu9jWxbqz5eMqeTDc4xZhOzPlgoEqGh5PmxOqlf8ZY.css" media="all" />
<!--<![endif]-->
<link type="text/css" rel="stylesheet" href="https://www.medrxiv.org/sites/default/files/advagg_css/css__GJ_y0JYBjHihOcdJg-wLEQWRfqvBxU74PCdjUcUHlyY__f0nQteVSjWTKq2ga8E2qYttGognShmPZZJdeGhQoNFI__OWu9jWxbqz5eMqeTDc4xZhOzPlgoEqGh5PmxOqlf8ZY.css" media="all" />
<link type="text/css" rel="stylesheet" href="https://d33xdlntwy0kbs.cloudfront.net/cshl_custom_medrxiv.css" media="all" />
    <script type="text/javascript" src="https://www.medrxiv.org/sites/default/files/advagg_js/js__BKYqkKToQ7EjirB7eIdMEH5521EU3da9IpoOs8Ex2XI__aSjVoX8giBmLhN2EbCgIGQJNu89Mh5aVu1LvI_gkJ7Y__OWu9jWxbqz5eMqeTDc4xZhOzPlgoEqGh5PmxOqlf8ZY.js"></script>
<script type="text/javascript" src="//cdn.jsdelivr.net/qtip2/2.2.1/jquery.qtip.min.js"></script>
<script type="text/javascript" src="https://www.medrxiv.org/sites/default/files/advagg_js/js__4Cn2dxvNlsJ-sHe6QOTLREaQvcqb0Yh0Zm9tTOHtQow__DGggC5UtYkPCwIH8nsa7Vw7hug93fb9QVVl0UJ3mfMM__OWu9jWxbqz5eMqeTDc4xZhOzPlgoEqGh5PmxOqlf8ZY.js"></script>
<script type="text/javascript" src="https://www.google.com/recaptcha/api.js?hl=en&amp;render=explicit&amp;onload=drupalRecaptchaOnload"></script>
<script type="text/javascript" src="https://www.medrxiv.org/sites/default/files/advagg_js/js__dGWpV57YWu3sX6UOe04RMH-iP9jSkEP7Ajt0caYXZZk__sUEhH4BzLc9Xn679uyzc7yvwgMkxjsks2WFVnFK0PiI__OWu9jWxbqz5eMqeTDc4xZhOzPlgoEqGh5PmxOqlf8ZY.js"></script>
<script type="text/javascript" async="async" src="https://scholar.google.com/scholar_js/casa.js"></script>
<script type="text/javascript">
<!--//--><![CDATA[//><!--
/*!
 * yepnope1.5.4
 * (c) WTFPL, GPLv2
 */
(function(a,b,c){function d(a){return"[object Function]"==o.call(a)}function e(a){return"string"==typeof a}function f(){}function g(a){return!a||"loaded"==a||"complete"==a||"uninitialized"==a}function h(){var a=p.shift();q=1,a?a.t?m(function(){("c"==a.t?B.injectCss:B.injectJs)(a.s,0,a.a,a.x,a.e,1)},0):(a(),h()):q=0}function i(a,c,d,e,f,i,j){function k(b){if(!o&&g(l.readyState)&&(u.r=o=1,!q&&h(),l.onload=l.onreadystatechange=null,b)){"img"!=a&&m(function(){t.removeChild(l)},50);for(var d in y[c])y[c].hasOwnProperty(d)&&y[c][d].onload()}}var j=j||B.errorTimeout,l=b.createElement(a),o=0,r=0,u={t:d,s:c,e:f,a:i,x:j};1===y[c]&&(r=1,y[c]=[]),"object"==a?l.data=c:(l.src=c,l.type=a),l.width=l.height="0",l.onerror=l.onload=l.onreadystatechange=function(){k.call(this,r)},p.splice(e,0,u),"img"!=a&&(r||2===y[c]?(t.insertBefore(l,s?null:n),m(k,j)):y[c].push(l))}function j(a,b,c,d,f){return q=0,b=b||"j",e(a)?i("c"==b?v:u,a,b,this.i++,c,d,f):(p.splice(this.i++,0,a),1==p.length&&h()),this}function k(){var a=B;return a.loader={load:j,i:0},a}var l=b.documentElement,m=a.setTimeout,n=b.getElementsByTagName("script")[0],o={}.toString,p=[],q=0,r="MozAppearance"in l.style,s=r&&!!b.createRange().compareNode,t=s?l:n.parentNode,l=a.opera&&"[object Opera]"==o.call(a.opera),l=!!b.attachEvent&&!l,u=r?"object":l?"script":"img",v=l?"script":u,w=Array.isArray||function(a){return"[object Array]"==o.call(a)},x=[],y={},z={timeout:function(a,b){return b.length&&(a.timeout=b[0]),a}},A,B;B=function(a){function b(a){var a=a.split("!"),b=x.length,c=a.pop(),d=a.length,c={url:c,origUrl:c,prefixes:a},e,f,g;for(f=0;f<d;f++)g=a[f].split("="),(e=z[g.shift()])&&(c=e(c,g));for(f=0;f<b;f++)c=x[f](c);return c}function g(a,e,f,g,h){var i=b(a),j=i.autoCallback;i.url.split(".").pop().split("?").shift(),i.bypass||(e&&(e=d(e)?e:e[a]||e[g]||e[a.split("/").pop().split("?")[0]]),i.instead?i.instead(a,e,f,g,h):(y[i.url]?i.noexec=!0:y[i.url]=1,f.load(i.url,i.forceCSS||!i.forceJS&&"css"==i.url.split(".").pop().split("?").shift()?"c":c,i.noexec,i.attrs,i.timeout),(d(e)||d(j))&&f.load(function(){k(),e&&e(i.origUrl,h,g),j&&j(i.origUrl,h,g),y[i.url]=2})))}function h(a,b){function c(a,c){if(a){if(e(a))c||(j=function(){var a=[].slice.call(arguments);k.apply(this,a),l()}),g(a,j,b,0,h);else if(Object(a)===a)for(n in m=function(){var b=0,c;for(c in a)a.hasOwnProperty(c)&&b++;return b}(),a)a.hasOwnProperty(n)&&(!c&&!--m&&(d(j)?j=function(){var a=[].slice.call(arguments);k.apply(this,a),l()}:j[n]=function(a){return function(){var b=[].slice.call(arguments);a&&a.apply(this,b),l()}}(k[n])),g(a[n],j,b,n,h))}else!c&&l()}var h=!!a.test,i=a.load||a.both,j=a.callback||f,k=j,l=a.complete||f,m,n;c(h?a.yep:a.nope,!!i),i&&c(i)}var i,j,l=this.yepnope.loader;if(e(a))g(a,0,l,0);else if(w(a))for(i=0;i<a.length;i++)j=a[i],e(j)?g(j,0,l,0):w(j)?B(j):Object(j)===j&&h(j,l);else Object(a)===a&&h(a,l)},B.addPrefix=function(a,b){z[a]=b},B.addFilter=function(a){x.push(a)},B.errorTimeout=1e4,null==b.readyState&&b.addEventListener&&(b.readyState="loading",b.addEventListener("DOMContentLoaded",A=function(){b.removeEventListener("DOMContentLoaded",A,0),b.readyState="complete"},0)),a.yepnope=k(),a.yepnope.executeStack=h,a.yepnope.injectJs=function(a,c,d,e,i,j){var k=b.createElement("script"),l,o,e=e||B.errorTimeout;k.src=a;for(o in d)k.setAttribute(o,d[o]);c=j?h:c||f,k.onreadystatechange=k.onload=function(){!l&&g(k.readyState)&&(l=1,c(),k.onload=k.onreadystatechange=null)},m(function(){l||(l=1,c(1))},e),i?k.onload():n.parentNode.insertBefore(k,n)},a.yepnope.injectCss=function(a,c,d,e,g,i){var e=b.createElement("link"),j,c=i?h:c||f;e.href=a,e.rel="stylesheet",e.type="text/css";for(j in d)e.setAttribute(j,d[j]);g||(n.parentNode.insertBefore(e,n),m(c,0))}})(this,document);

//--><!]]>
</script>
<script type="text/javascript">
<!--//--><![CDATA[//><!--
yepnope({
  test: Modernizr.matchmedia,
  nope: '/sites/all/libraries/media-match/media.match.min.js'
});
//--><!]]>
</script>
<script type="text/javascript">
<!--//--><![CDATA[//><!--
var _prum=[['id', '52e95df3abe53d2e33000000'], ['mark', 'firstbyte',
      (new Date()).getTime()]]; (function() {
      var s=document.getElementsByTagName('script')[0],
      p=document.createElement('script');
      p.async='async'; p.src='//rum-static.pingdom.net/prum.min.js';s.parentNode.insertBefore(p,s);})();
//--><!]]>
</script>
<script type="text/javascript">
<!--//--><![CDATA[//><!--
if(typeof window.MathJax === "undefined") window.MathJax = { menuSettings: { zoom: "Click" } };
//--><!]]>
</script>
<script type="text/javascript">
<!--//--><![CDATA[//><!--
(function(i,s,o,g,r,a,m){i["GoogleAnalyticsObject"]=r;i[r]=i[r]||function(){(i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)})(window,document,"script","//www.google-analytics.com/analytics.js","ga");ga("create", "UA-141606356-1", {"cookieDomain":"auto"});ga("set", "page", location.pathname + location.search + location.hash);ga("send", "pageview");ga('create', 'UA-189672-38', 'auto', {'name': 'hwTracker'});
ga('set', 'anonymizeIp', true);
ga('hwTracker.send', 'pageview');
//--><!]]>
</script>
<script type="text/javascript">
<!--//--><![CDATA[//><!--
jQuery.extend(Drupal.settings,{"basePath":"\/","pathPrefix":"","ajaxPageState":{"theme":"jcore_1","theme_token":"1JLyoRwdB7QSlZG5HD89_5tyILC6uElURhDD34ltUbM"},"colorbox":{"opacity":"0.85","current":"{current} of {total}","previous":"\u00ab Prev","next":"Next \u00bb","close":"Close","maxWidth":"98%","maxHeight":"98%","fixed":true,"mobiledetect":true,"mobiledevicewidth":"480px"},"highwire":{"nid":"71120","apath":"\/medrxiv\/early\/2020\/01\/10\/2020.01.08.20016915.atom","pisa":"medrxiv;2020.01.08.20016915v1","markup":[{"requested":"index","variant":"index","view":"full","pisa":"medrxiv;2020.01.08.20016915\/DC1"},{"requested":"abstract","variant":"abstract","view":"abstract","pisa":"medrxiv;2020.01.08.20016915v1"},{"requested":"index","variant":"index","view":"full","pisa":"medrxiv;2020.01.08.20016915\/DC1"}],"ac":{"\/medrxiv\/early\/2020\/01\/10\/2020.01.08.20016915.atom":{"access":{"full":true},"pisa_id":"","apath":"\/medrxiv\/early\/2020\/01\/10\/2020.01.08.20016915.atom","jcode":"medrxiv"}},"processed":["highwire_math"],"modal_window_width":"560","share_modal_width":"560","share_modal_title":"Share this Article"},"jcarousel":{"ajaxPath":"\/jcarousel\/ajax\/views"},"instances":"{\u0022highwire_abstract_tooltip\u0022:{\u0022content\u0022:{\u0022text\u0022:\u0022\u0022},\u0022style\u0022:{\u0022tip\u0022:{\u0022width\u0022:20,\u0022height\u0022:20,\u0022border\u0022:1,\u0022offset\u0022:0,\u0022corner\u0022:true},\u0022classes\u0022:\u0022qtip-custom hw-tooltip hw-abstract-tooltip qtip-shadow qtip-rounded\u0022,\u0022classes_custom\u0022:\u0022hw-tooltip hw-abstract-tooltip\u0022},\u0022position\u0022:{\u0022at\u0022:\u0022right center\u0022,\u0022my\u0022:\u0022left center\u0022,\u0022viewport\u0022:true,\u0022adjust\u0022:{\u0022method\u0022:\u0022shift\u0022}},\u0022show\u0022:{\u0022event\u0022:\u0022mouseenter click \u0022,\u0022solo\u0022:true},\u0022hide\u0022:{\u0022event\u0022:\u0022mouseleave \u0022,\u0022fixed\u0022:1,\u0022delay\u0022:\u0022100\u0022}},\u0022highwire_author_tooltip\u0022:{\u0022content\u0022:{\u0022text\u0022:\u0022\u0022},\u0022style\u0022:{\u0022tip\u0022:{\u0022width\u0022:15,\u0022height\u0022:15,\u0022border\u0022:1,\u0022offset\u0022:0,\u0022corner\u0022:true},\u0022classes\u0022:\u0022qtip-custom hw-tooltip hw-author-tooltip qtip-shadow qtip-rounded\u0022,\u0022classes_custom\u0022:\u0022hw-tooltip hw-author-tooltip\u0022},\u0022position\u0022:{\u0022at\u0022:\u0022top center\u0022,\u0022my\u0022:\u0022bottom center\u0022,\u0022viewport\u0022:true,\u0022adjust\u0022:{\u0022method\u0022:\u0022\u0022}},\u0022show\u0022:{\u0022event\u0022:\u0022mouseenter \u0022,\u0022solo\u0022:true},\u0022hide\u0022:{\u0022event\u0022:\u0022mouseleave \u0022,\u0022fixed\u0022:1,\u0022delay\u0022:\u0022100\u0022}},\u0022highwire_reflinks_tooltip\u0022:{\u0022content\u0022:{\u0022text\u0022:\u0022\u0022},\u0022style\u0022:{\u0022tip\u0022:{\u0022width\u0022:15,\u0022height\u0022:15,\u0022border\u0022:1,\u0022mimic\u0022:\u0022top center\u0022,\u0022offset\u0022:0,\u0022corner\u0022:true},\u0022classes\u0022:\u0022qtip-custom hw-tooltip hw-ref-link-tooltip qtip-shadow qtip-rounded\u0022,\u0022classes_custom\u0022:\u0022hw-tooltip hw-ref-link-tooltip\u0022},\u0022position\u0022:{\u0022at\u0022:\u0022bottom left\u0022,\u0022my\u0022:\u0022top left\u0022,\u0022viewport\u0022:true,\u0022adjust\u0022:{\u0022method\u0022:\u0022flip\u0022}},\u0022show\u0022:{\u0022event\u0022:\u0022mouseenter \u0022,\u0022solo\u0022:true},\u0022hide\u0022:{\u0022event\u0022:\u0022mouseleave \u0022,\u0022fixed\u0022:1,\u0022delay\u0022:\u0022100\u0022}}}","qtipDebug":"{\u0022leaveElement\u0022:0}","panel_ajax_tab":{"path":"sites\/all\/modules\/contrib\/panels_ajax_tab"},"disqus":{"domain":"medRxiv","url":"https:\/\/www.medrxiv.org\/content\/10.1101\/2020.01.08.20016915v1","title":"Efficacy and Safety of PD-1\/PD-L1 plus CTLA-4 antibodies +\/\u2212 Other Therapies in Lung Cancer: A Systematic Review and Meta-Analysis","identifier":"node\/71120"},"panels_ajax_pane":{"new-41":"{\u0022encrypted\u0022:\u0022{\\\u0022encrypted\\\u0022:\\\u0022q+FG+6z9bEtyTGHu7hyvxJZ+HlGq+bpObNxmVoGGoRn+Q8Jmq771DPCKOIwoVHgNLm+fpEdA54vR5Om+ZWUB8VXYFTNtaMbnCsTYm5onp4O4h\\\\\\\/1nUWb7R8UkTBX3o\\\\\\\/vmHKr2LZPKSXGBWdcqWfju4vS2NFFTWFbZDmIkUs10EsbYSz0TjjZ0B2g4nqSL0kKwlnmRe6QQch9n3k+ZIrHYSlFk0MO7NbBwbK56MH1qe5ALFecvutneH12O7NjIuxuYsJjipAZOLqNR254qEStNluDoS4jlwNFC4wRga8xTboWqN5qR20eX5ALKIToAB+CR6ZbD3MZ94nRd32UdIGF7FJcC8167ytsoR+SlecrTuyiJUDsCR5CLKpaGSPodd8y5ucxdPjn3bO3rnRqZoY3TnsX3gMuuylNOrn0z0atizrH0eEwaCv2bFeqzzsFsANz+GsERXjkBYtzT6hVVQPitKa+QVb4\\\\\\\/4u5NgskkXvIGU3QPucbNM6w5i144WDzlI9svyAQbr0b1TXH64rPw5n3LRfbJU1NUj2nzPB0uX\\\\\\\/a\\\\\\\/WFSZgixbsqbo2OIg2wRdCa4bHj5EQsPgOWGzctGRCTLSnVr86tlUSLYhH4D3hmxU50vtFRbSVOBt+A382cJtdUIRkOYL+16gljUDyi0HHvPaPT5wh+YUGVrPJF7xCuwEJJ5daKFoaqw5c7tMnl8zFIyIYGtewei+9kfTRmhYldhmHZKobZMGAazVvi4FwDtJ5\\\\\\\/d+8oTsjCZHo9pIurG83DHqLIZGY+o+5d0JbdiXuaSGNm2AAvnvp0Pz\\\\\\\/G+nN60qReN8rylOssE\\\\\\\/Bp7KG+eiQtC9oSQYRqO\\\\\\\/TJSxlPf2VZNWCO\\\\\\\/aPfYyBJbC7fjwwPXMd5Cwk5xdJP4DfUMh3SOx48nVC+O+t6EiD62zW8N5grSOHLP9UJdWvkIvUimWtmo91t2qPXgz18bD7S3AbIszdPOIGEg+NugqYx7Q3RAy6Uz6lX4eDMPhVeCl\\\\\\\/8Cfe6P1r\\\\\\\/Jdo6XjN4w9cmhn\\\\\\\/CwEa1QiXHPCPP0I2pOVTsov7Z+cYbxabPDacBqWL62H7JY5y6JYtBMzoO18qTigiBIwpGe\\\\\\\/Ieq2HrlnhBGd4Aj7q+IRsQ1nMR0qBEHW\\\\\\\/Dy25I+uwL\\\\\\\/T7VxGVv1DG5v4ROCBhVe8AcWA\\\\\\\/4LMl1I3QP2Bopdwpp8O3dmwhyt\\\\\\\/0bpeRJIiwuimJV7azTHhD26MkI9gMnzh0\\\\\\\/XG2wHmy5zO6cjAChs4YsvNGwFRRV5\\\\\\\/qfiESSAXwhnyRh9fO9u0yorCZtpys7FV\\\u0022,\\\u0022iv\\\u0022:\\\u0022KvObLFtUh8g9IJMNHVrIww==\\\u0022,\\\u0022salt\\\u0022:\\\u0022f9d8845712f72c9fee5db7d9ff111eab\\\u0022}\u0022,\u0022hmac\u0022:\u0022baa6bcc585115430acae78a7f41c80ff1e06a296efb0a71eace3a49654d9f44b\u0022}"},"urlIsAjaxTrusted":{"\/content\/10.1101\/2020.01.08.20016915v1":true},"ws_fl":{"width":100,"height":21},"ws_gpo":{"size":"","annotation":"","lang":"","callback":"","width":300},"color":{"logo":"https:\/\/www.medrxiv.org\/sites\/default\/files\/medrxiv_internal_logo.png"},"highwire_list_expand":{"is_collapsed":"1"},"highwireResponsive":{"enquire_enabled":1,"breakpoints_configured":1,"breakpoints":{"zero":"all and (min-width: 0px)","xsmall":"all and (min-width: 380px)","narrow":"all and (min-width: 768px) and (min-device-width: 768px), (max-device-width: 800px) and (min-width: 768px) and (orientation:landscape)","normal":"all and (min-width: 980px) and (min-device-width: 980px), all and (max-device-width: 1024px) and (min-width: 1024px) and (orientation:landscape)","wide":"all and (min-width: 1220px)"}},"eu_cookie_compliance":{"popup_enabled":1,"popup_agreed_enabled":0,"popup_hide_agreed":0,"popup_clicking_confirmation":1,"popup_scrolling_confirmation":false,"popup_html_info":"\u003Cdiv\u003E\n  \u003Cdiv class =\u0022popup-content info\u0022\u003E\n    \u003Cdiv id=\u0022popup-text\u0022\u003E\n      \u003Cp\u003EWe use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.\u003C\/p\u003E\n    \u003C\/div\u003E\n    \u003Cdiv id=\u0022popup-buttons\u0022\u003E\n      \u003Cbutton type=\u0022button\u0022 class=\u0022agree-button eu-cookie-compliance-default-button\u0022\u003EContinue\u003C\/button\u003E\n                    \u003Cbutton type=\u0022button\u0022 class=\u0022find-more-button eu-cookie-compliance-more-button\u0022\u003EFind out more\u003C\/button\u003E\n          \u003C\/div\u003E\n  \u003C\/div\u003E\n\u003C\/div\u003E","use_mobile_message":false,"mobile_popup_html_info":"\u003Cdiv\u003E\n  \u003Cdiv class =\u0022popup-content info\u0022\u003E\n    \u003Cdiv id=\u0022popup-text\u0022\u003E\n          \u003C\/div\u003E\n    \u003Cdiv id=\u0022popup-buttons\u0022\u003E\n      \u003Cbutton type=\u0022button\u0022 class=\u0022agree-button eu-cookie-compliance-default-button\u0022\u003EContinue\u003C\/button\u003E\n                    \u003Cbutton type=\u0022button\u0022 class=\u0022find-more-button eu-cookie-compliance-more-button\u0022\u003EFind out more\u003C\/button\u003E\n          \u003C\/div\u003E\n  \u003C\/div\u003E\n\u003C\/div\u003E\n","mobile_breakpoint":"768","popup_html_agreed":"\u003Cdiv\u003E\n  \u003Cdiv class=\u0022popup-content agreed\u0022\u003E\n    \u003Cdiv id=\u0022popup-text\u0022\u003E\n      \u003Ch2\u003EThank you for accepting cookies\u003C\/h2\u003E\u003Cp\u003EYou can now hide this message or find out more about cookies.\u003C\/p\u003E    \u003C\/div\u003E\n    \u003Cdiv id=\u0022popup-buttons\u0022\u003E\n      \u003Cbutton type=\u0022button\u0022 class=\u0022hide-popup-button eu-cookie-compliance-hide-button\u0022\u003EHide\u003C\/button\u003E\n              \u003Cbutton type=\u0022button\u0022 class=\u0022find-more-button eu-cookie-compliance-more-button-thank-you\u0022 \u003EMore info\u003C\/button\u003E\n          \u003C\/div\u003E\n  \u003C\/div\u003E\n\u003C\/div\u003E","popup_use_bare_css":false,"popup_height":"auto","popup_width":"100%","popup_delay":1000,"popup_link":"\/help\/cookie-policy","popup_link_new_window":1,"popup_position":null,"popup_language":"en","store_consent":false,"better_support_for_screen_readers":0,"reload_page":0,"domain":"","popup_eu_only_js":0,"cookie_lifetime":"365","cookie_session":false,"disagree_do_not_show_popup":0,"method":"default","whitelisted_cookies":"","withdraw_markup":"\u003Cbutton type=\u0022button\u0022 class=\u0022eu-cookie-withdraw-tab\u0022\u003EPrivacy settings\u003C\/button\u003E\n\u003Cdiv class=\u0022eu-cookie-withdraw-banner\u0022\u003E\n  \u003Cdiv class=\u0022popup-content info\u0022\u003E\n    \u003Cdiv id=\u0022popup-text\u0022\u003E\n      \u003Cp\u003E\u0026lt;h2\u0026gt;We use cookies on this site to enhance your user experience\u0026lt;\/h2\u0026gt;\u0026lt;p\u0026gt;You have given your consent for us to set cookies.\u0026lt;\/p\u0026gt;\u003C\/p\u003E\n    \u003C\/div\u003E\n    \u003Cdiv id=\u0022popup-buttons\u0022\u003E\n      \u003Cbutton type=\u0022button\u0022 class=\u0022eu-cookie-withdraw-button\u0022\u003EWithdraw consent\u003C\/button\u003E\n    \u003C\/div\u003E\n  \u003C\/div\u003E\n\u003C\/div\u003E\n","withdraw_enabled":false},"googleanalytics":{"trackOutbound":1,"trackMailto":1,"trackDownload":1,"trackDownloadExtensions":"7z|aac|arc|arj|asf|asx|avi|bin|csv|doc(x|m)?|dot(x|m)?|exe|flv|gif|gz|gzip|hqx|jar|jpe?g|js|mp(2|3|4|e?g)|mov(ie)?|msi|msp|pdf|phps|png|ppt(x|m)?|pot(x|m)?|pps(x|m)?|ppam|sld(x|m)?|thmx|qtm?|ra(m|r)?|sea|sit|tar|tgz|torrent|txt|wav|wma|wmv|wpd|xls(x|m|b)?|xlt(x|m)|xlam|xml|z|zip","trackColorbox":1,"trackUrlFragments":1},"jnl_biorxiv_styles":{"defaultJCode":"medrxiv"},"omega":{"layouts":{"primary":"normal","order":["narrow","normal","wide"],"queries":{"narrow":"all and (min-width: 768px) and (min-device-width: 768px), (max-device-width: 800px) and (min-width: 768px) and (orientation:landscape)","normal":"all and (min-width: 980px) and (min-device-width: 980px), all and (max-device-width: 1024px) and (min-width: 1024px) and (orientation:landscape)","wide":"all and (min-width: 1220px)"}}}});
//--><!]]>
</script>
    <!--[if lt IE 9]><script src="http://html5shiv.googlecode.com/svn/trunk/html5.js"></script><![endif]-->
  </head>
  <body class="html not-front not-logged-in page-node page-node- page-node-71120 node-type-highwire-article context-content hw-default-jcode-medrxiv hw-article-type-article">
<!-- Google Tag Manager -->
<noscript><iframe src="//www.googletagmanager.com/ns.html?id=GTM-P4HH5NV" height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript>
<script type="text/javascript">(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0];var j=d.createElement(s);var dl=l!='dataLayer'?'&l='+l:'';j.src='//www.googletagmanager.com/gtm.js?id='+i+dl;j.type='text/javascript';j.async=true;f.parentNode.insertBefore(j,f);})(window,document,'script','dataLayer','GTM-P4HH5NV');</script>
<!-- End Google Tag Manager -->
    <div id="skip-link">
      <a href="#main-content" class="element-invisible element-focusable">Skip to main content</a>
    </div>
        <div class="page clearfix page-box-shadows footer-borders panels-page panels-layout-jcore_2col" id="page">
      <header id="section-header" class="section section-header">
    
  <div id="zone-branding" class="zone zone-branding clearfix print-display-block container-30">
    <div class="grid-15 prefix-1 region region-branding print-display-block" id="region-branding">
  <div class="region-inner region-branding-inner">
        <div class="branding-data clearfix">
            <div class="logo-img">
        <a href="/" rel="home" class="" data-icon-position="" data-hide-link-title="0"><img alt="medRxiv" src="https://www.medrxiv.org/sites/default/files/medrxiv_internal_logo.png" /></a>      </div>
                </div>
          </div>
</div><div class="grid-11 suffix-1 region region-branding-second print-hidden" id="region-branding-second">
  <div class="region-inner region-branding-second-inner">
    <div class="block block-system block-menu block-main-menu block-system-main-menu odd block-without-title" id="block-system-main-menu">
  <div class="block-inner clearfix">
                
    <div class="content clearfix">
      <nav class="menubar-nav"><ul class="menu" role="menu"><li class="first leaf" role="menuitem"><a href="/" title="" class="" data-icon-position="" data-hide-link-title="0">Home</a></li>
<li class="leaf" role="menuitem"><a href="/content/about-medrxiv" class="" data-icon-position="" data-hide-link-title="0">About</a></li>
<li class="leaf" role="menuitem"><a href="/submit-a-manuscript" class="" data-icon-position="" data-hide-link-title="0">Submit</a></li>
<li class="last leaf" role="menuitem"><a href="/content/alertsrss" title="" class="" data-icon-position="" data-hide-link-title="0">ALERTS / RSS</a></li>
</ul></nav>    </div>
  </div>
</div><div class="block block-panels-mini block-biorxiv-search-box block-panels-mini-biorxiv-search-box even block-without-title" id="block-panels-mini-biorxiv-search-box">
  <div class="block-inner clearfix">
                
    <div class="content clearfix">
      <div class="panel-display panel-1col clearfix" id="mini-panel-biorxiv_search_box">
  <div class="panel-panel panel-col">
    <div><div class="panel-pane pane-highwire-seach-quicksearch" >
  
      
  
  <div class="pane-content">
    <form class="highwire-quicksearch button-style-mini button-style-mini" action="/content/10.1101/2020.01.08.20016915v1" method="post" id="highwire-search-quicksearch-form-0" accept-charset="UTF-8"><div><div class="form-item form-item-label-invisible form-type-textfield form-item-keywords">
  <label class="element-invisible" for="edit-keywords">Search for this keyword </label>
 <input placeholder="Search" type="text" id="edit-keywords" name="keywords" value="" size="60" maxlength="128" class="form-text" />
</div>
<div class="button-wrapper button-mini"><span class="icon-search"></span><input data-icon-only="1" data-font-icon="icon-search" data-icon-position="after" type="submit" id="edit-submit--2" name="op" value="Search" class="form-submit" /></div><input type="hidden" name="form_build_id" value="form-nhQVFSprGu-j0A2nd9EfKTPACN3dLB4USiSQg_400ds" />
<input type="hidden" name="form_id" value="highwire_search_quicksearch_form_0" />
</div></form>  </div>

  
  </div>
<div class="panel-separator"></div><div class="panel-pane pane-custom pane-2 advanced-search-link" >
  
      
  
  <div class="pane-content">
    <a href="/search">Advanced Search</a>  </div>

  
  </div>
</div>
  </div>
</div>
    </div>
  </div>
</div>  </div>
</div>  </div>
  
  <div id="zone-header" class="zone zone-header clearfix container-30">
  	      </div>
</header>    
      <section id="section-content" class="section section-content">
    
  <div id="zone-content" class="zone zone-content clearfix container-30">    
        
    <div class="grid-28 suffix-1 prefix-1 region region-content" id="region-content">
  <div class="region-inner region-content-inner">
    <a id="main-content"></a>
                        <div class="block block-system block-main block-system-main odd block-without-title" id="block-system-main">
  <div class="block-inner clearfix">
                
    <div class="content clearfix">
      <div class="panel-display panels-960-layout jcore-2col-layout" >
	  
  <div class="panel-row-wrapper clearfix">
		
		<div class="main-content-wrapper grid-17 suffix-1 alpha">
			<div class="panel-panel panel-region-content">
			  <div class="inside"><div class="panel-pane pane-highwire-article-citation" >
  
      
  
  <div class="pane-content">
    <div class="highwire-article-citation highwire-citation-type-highwire-article node71120" data-node-nid="71120" id="node71120--22060352032" data-pisa="medrxiv;2020.01.08.20016915v1" data-pisa-master="medrxiv;2020.01.08.20016915" data-apath="/medrxiv/early/2020/01/10/2020.01.08.20016915.atom" data-hw-author-tooltip-instance=""><div  class="highwire-cite highwire-cite-highwire-article highwire-citation-medrxiv-article-top clearfix has-author-tooltip" >

  
      <h1 class="highwire-cite-title" id="page-title">Efficacy and Safety of PD-1/PD-L1 plus CTLA-4 antibodies +/− Other Therapies in Lung Cancer: A Systematic Review and Meta-Analysis</h1>  
      <div  class="highwire-cite-authors" ><span  class="highwire-citation-authors"><span class="highwire-citation-author first" data-delta="0"><span class="nlm-given-names">Xiang</span> <span class="nlm-surname">Shen</span></span>, <span class="highwire-citation-author" data-delta="1"><span class="nlm-given-names">Hua</span> <span class="nlm-surname">Xiao</span></span>, <span class="highwire-citation-author" data-delta="2"><span class="nlm-given-names">Shangke</span> <span class="nlm-surname">Huang</span></span>, <span class="highwire-citation-author" data-delta="3"><span class="nlm-given-names">Jiexing</span> <span class="nlm-surname">Liu</span></span>, <span class="highwire-citation-author" data-delta="4"><span class="nlm-given-names">Zhuolan</span> <span class="nlm-surname">Ran</span></span>, <span class="highwire-citation-author" data-delta="5"><span class="nlm-given-names">Bin</span> <span class="nlm-surname">Xiong</span></span></span></div>
  
      <div  class="highwire-cite-metadata" ><span  class="highwire-cite-metadata-doi highwire-cite-metadata"><span class="label">doi:</span> https://doi.org/10.1101/2020.01.08.20016915 </span></div>
  
  
  
</div>
<div id="hw-article-author-popups-node71120--22060352032" style="display: none;"><div class="author-tooltip-0"><div class="author-tooltip-name">Xiang Shen </div><div class="author-tooltip-affiliation"><span class="author-tooltip-text"><div class='author-affiliation'><span class='nlm-sup'>1</span><span class='nlm-institution'>Department of Respiratory Medicine, The Affiliated Hospital of Southwest Medical University</span>, Luzhou, Sichuan, <span class='nlm-country'>China</span>, 646000</div></span></div><ul class="author-tooltip-find-more"><li class="author-tooltip-gs-link first"><a href="/lookup/google-scholar?link_type=googlescholar&amp;gs_type=author&amp;author%5B0%5D=Xiang%2BShen%2B" target="_blank" class="" data-icon-position="" data-hide-link-title="0">Find this author on Google Scholar</a></li><li class="author-tooltip-pubmed-link"><a href="/lookup/external-ref?access_num=Shen%20X&amp;link_type=AUTHORSEARCH" target="_blank" class="" data-icon-position="" data-hide-link-title="0">Find this author on PubMed</a></li><li class="author-site-search-link last"><a href="/search/author1%3AXiang%2BShen%2B" rel="nofollow" class="" data-icon-position="" data-hide-link-title="0">Search for this author on this site</a></li></ul></div><div class="author-tooltip-1"><div class="author-tooltip-name">Hua Xiao </div><div class="author-tooltip-affiliation"><span class="author-tooltip-text"><div class='author-affiliation'><span class='nlm-sup'>1</span><span class='nlm-institution'>Department of Respiratory Medicine, The Affiliated Hospital of Southwest Medical University</span>, Luzhou, Sichuan, <span class='nlm-country'>China</span>, 646000</div></span></div><ul class="author-tooltip-find-more"><li class="author-tooltip-gs-link first"><a href="/lookup/google-scholar?link_type=googlescholar&amp;gs_type=author&amp;author%5B0%5D=Hua%2BXiao%2B" target="_blank" class="" data-icon-position="" data-hide-link-title="0">Find this author on Google Scholar</a></li><li class="author-tooltip-pubmed-link"><a href="/lookup/external-ref?access_num=Xiao%20H&amp;link_type=AUTHORSEARCH" target="_blank" class="" data-icon-position="" data-hide-link-title="0">Find this author on PubMed</a></li><li class="author-site-search-link last"><a href="/search/author1%3AHua%2BXiao%2B" rel="nofollow" class="" data-icon-position="" data-hide-link-title="0">Search for this author on this site</a></li></ul></div><div class="author-tooltip-2"><div class="author-tooltip-name">Shangke Huang </div><div class="author-tooltip-affiliation"><span class="author-tooltip-text"><div class='author-affiliation'><span class='nlm-sup'>2</span><span class='nlm-institution'>Oncology Department, The Affiliated Hospital of Southwest Medical University</span>, Luzhou, Sichuan, <span class='nlm-country'>China</span>, 646000</div></span></div><ul class="author-tooltip-find-more"><li class="author-tooltip-gs-link first"><a href="/lookup/google-scholar?link_type=googlescholar&amp;gs_type=author&amp;author%5B0%5D=Shangke%2BHuang%2B" target="_blank" class="" data-icon-position="" data-hide-link-title="0">Find this author on Google Scholar</a></li><li class="author-tooltip-pubmed-link"><a href="/lookup/external-ref?access_num=Huang%20S&amp;link_type=AUTHORSEARCH" target="_blank" class="" data-icon-position="" data-hide-link-title="0">Find this author on PubMed</a></li><li class="author-site-search-link last"><a href="/search/author1%3AShangke%2BHuang%2B" rel="nofollow" class="" data-icon-position="" data-hide-link-title="0">Search for this author on this site</a></li></ul></div><div class="author-tooltip-3"><div class="author-tooltip-name">Jiexing Liu </div><div class="author-tooltip-affiliation"><span class="author-tooltip-text"><div class='author-affiliation'><span class='nlm-sup'>1</span><span class='nlm-institution'>Department of Respiratory Medicine, The Affiliated Hospital of Southwest Medical University</span>, Luzhou, Sichuan, <span class='nlm-country'>China</span>, 646000</div></span></div><ul class="author-tooltip-find-more"><li class="author-tooltip-gs-link first"><a href="/lookup/google-scholar?link_type=googlescholar&amp;gs_type=author&amp;author%5B0%5D=Jiexing%2BLiu%2B" target="_blank" class="" data-icon-position="" data-hide-link-title="0">Find this author on Google Scholar</a></li><li class="author-tooltip-pubmed-link"><a href="/lookup/external-ref?access_num=Liu%20J&amp;link_type=AUTHORSEARCH" target="_blank" class="" data-icon-position="" data-hide-link-title="0">Find this author on PubMed</a></li><li class="author-site-search-link last"><a href="/search/author1%3AJiexing%2BLiu%2B" rel="nofollow" class="" data-icon-position="" data-hide-link-title="0">Search for this author on this site</a></li></ul></div><div class="author-tooltip-4"><div class="author-tooltip-name">Zhuolan Ran </div><div class="author-tooltip-affiliation"><span class="author-tooltip-text"><div class='author-affiliation'><span class='nlm-sup'>1</span><span class='nlm-institution'>Department of Respiratory Medicine, The Affiliated Hospital of Southwest Medical University</span>, Luzhou, Sichuan, <span class='nlm-country'>China</span>, 646000</div></span></div><ul class="author-tooltip-find-more"><li class="author-tooltip-gs-link first"><a href="/lookup/google-scholar?link_type=googlescholar&amp;gs_type=author&amp;author%5B0%5D=Zhuolan%2BRan%2B" target="_blank" class="" data-icon-position="" data-hide-link-title="0">Find this author on Google Scholar</a></li><li class="author-tooltip-pubmed-link"><a href="/lookup/external-ref?access_num=Ran%20Z&amp;link_type=AUTHORSEARCH" target="_blank" class="" data-icon-position="" data-hide-link-title="0">Find this author on PubMed</a></li><li class="author-site-search-link last"><a href="/search/author1%3AZhuolan%2BRan%2B" rel="nofollow" class="" data-icon-position="" data-hide-link-title="0">Search for this author on this site</a></li></ul></div><div class="author-tooltip-5"><div class="author-tooltip-name">Bin Xiong </div><div class="author-tooltip-affiliation"><span class="author-tooltip-text"><div class='author-affiliation'><span class='nlm-sup'>1</span><span class='nlm-institution'>Department of Respiratory Medicine, The Affiliated Hospital of Southwest Medical University</span>, Luzhou, Sichuan, <span class='nlm-country'>China</span>, 646000</div></span></div><ul class="author-tooltip-find-more"><li class="author-tooltip-gs-link first"><a href="/lookup/google-scholar?link_type=googlescholar&amp;gs_type=author&amp;author%5B0%5D=Bin%2BXiong%2B" target="_blank" class="" data-icon-position="" data-hide-link-title="0">Find this author on Google Scholar</a></li><li class="author-tooltip-pubmed-link"><a href="/lookup/external-ref?access_num=Xiong%20B&amp;link_type=AUTHORSEARCH" target="_blank" class="" data-icon-position="" data-hide-link-title="0">Find this author on PubMed</a></li><li class="author-site-search-link"><a href="/search/author1%3ABin%2BXiong%2B" rel="nofollow" class="" data-icon-position="" data-hide-link-title="0">Search for this author on this site</a></li><li class="author-corresp-email-link last"><span>For correspondence: 
<a href="mailto:xionbin321@163.com" class="" data-icon-position="" data-hide-link-title="0">xionbin321@163.com</a></span></li></ul></div></div></div>  </div>

  
  </div>
<div class="panel-separator"></div><div class="panel-pane pane-highwire-panel-tabs pane-panels-ajax-tab-tabs" >
  
      
  
  <div class="pane-content">
    <div class="item-list"><ul class="tabs inline panels-ajax-tab"><li class="first"><a href="/content/10.1101/2020.01.08.20016915v1" class="panels-ajax-tab-tab" data-panel-name="biorxiv_tab_art" data-target-id="highwire_article_tabs" data-entity-context="node:71120" data-trigger="" data-url-enabled="1">Abstract</a><a href="/panels_ajax_tab/biorxiv_tab_art/node:71120/1" rel="nofollow" style="display:none" class="js-crawler-link"></a></li><li><a href="/content/10.1101/2020.01.08.20016915v1.full-text" class="panels-ajax-tab-tab" data-panel-name="article_tab_full_text" data-target-id="highwire_article_tabs" data-entity-context="node:71120" data-trigger="full-text" data-url-enabled="1">Full Text</a><a href="/panels_ajax_tab/article_tab_full_text/node:71120/1" rel="nofollow" style="display:none" class="js-crawler-link"></a></li><li><a href="/content/10.1101/2020.01.08.20016915v1.article-info" class="panels-ajax-tab-tab" data-panel-name="biorxiv_tab_info" data-target-id="highwire_article_tabs" data-entity-context="node:71120" data-trigger="article-info" data-url-enabled="1">Info/History</a><a href="/panels_ajax_tab/biorxiv_tab_info/node:71120/1" rel="nofollow" style="display:none" class="js-crawler-link"></a></li><li><a href="/content/10.1101/2020.01.08.20016915v1.article-metrics" class="panels-ajax-tab-tab" data-panel-name="article_tab_metrics" data-target-id="highwire_article_tabs" data-entity-context="node:71120" data-trigger="article-metrics" data-url-enabled="1">Metrics</a><a href="/panels_ajax_tab/article_tab_metrics/node:71120/1" rel="nofollow" style="display:none" class="js-crawler-link"></a></li><li><a href="/content/10.1101/2020.01.08.20016915v1.supplementary-material" class="panels-ajax-tab-tab" data-panel-name="biorxiv_tab_data" data-target-id="highwire_article_tabs" data-entity-context="node:71120" data-trigger="supplementary-material" data-url-enabled="1">Supplementary material</a><a href="/panels_ajax_tab/biorxiv_tab_data/node:71120/1" rel="nofollow" style="display:none" class="js-crawler-link"></a></li><li><a href="/content/10.1101/2020.01.08.20016915v1.external-links" class="panels-ajax-tab-tab" data-panel-name="article_tab_data_code" data-target-id="highwire_article_tabs" data-entity-context="node:71120" data-trigger="external-links" data-url-enabled="1">Data/Code</a><a href="/panels_ajax_tab/article_tab_data_code/node:71120/1" rel="nofollow" style="display:none" class="js-crawler-link"></a></li><li class="last"><a href="/content/10.1101/2020.01.08.20016915v1.full.pdf+html" class="panels-ajax-tab-tab" data-panel-name="biorxiv_tab_pdf" data-target-id="highwire_article_tabs" data-entity-context="node:71120" data-trigger="full.pdf+html" data-url-enabled="1"><i class="icon-file-alt"></i> Preview PDF</a><a href="/panels_ajax_tab/biorxiv_tab_pdf/node:71120/1" rel="nofollow" style="display:none" class="js-crawler-link"></a></li></ul></div>  </div>

  
  </div>
<div class="panel-separator"></div><div class="panel-pane pane-highwire-panel-tabs-container" >
  
      
  
  <div class="pane-content">
    <div data-panels-ajax-tab-preloaded="biorxiv_tab_art" id="panels-ajax-tab-container-highwire_article_tabs" class="panels-ajax-tab-container"><div class="panels-ajax-tab-loading" style ="display:none"><img class="loading" src="https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif" alt="Loading" title="Loading" /></div><div class="panels-ajax-tab-wrap-biorxiv_tab_art"><div class="panel-display panel-1col clearfix" >
  <div class="panel-panel panel-col">
    <div><div class="panel-pane pane-highwire-markup" >
  
      
  
  <div class="pane-content">
    <div class="highwire-markup"><div xmlns="http://www.w3.org/1999/xhtml" data-highwire-cite-ref-tooltip-instance="highwire_reflinks_tooltip" class="content-block-markup" xmlns:xhtml="http://www.w3.org/1999/xhtml"><div class="article abstract-view "><span class="highwire-journal-article-marker-start"></span><div class="section abstract" id="abstract-1"><h2 class="">ABSTRACT</h2><div id="sec-1" class="subsection"><p id="p-2"><strong>Background</strong> Immune checkpoint inhibitors have brought hope for patients with advanced lung cancer, among which PD-1/PD-L1 and CTLA-4 inhibitors have achieved considerable results. This meta-analysis aims to investigate the efficacy and safety of PD-1/PD-L1 combined with CTLA-4 antibodies in patients with advanced lung cancer.</p></div><div id="sec-2" class="subsection"><p id="p-3"><strong>Materials and Methods</strong> Randomized controlled trials (RCTs) study of PD-1/PD-L1 combined with CTLA-4 inhibitors for advanced lung cancer was searched in the database for systematic review and meta-analysis.</p></div><div id="sec-3" class="subsection"><p id="p-4"><strong>Results</strong> The meta-analysis finally included 4 trials (actually 3 trials), and the results showed that the overall response rate of PD-1/PD-L1 combined with CTLA-4 inhibitor was higher than that of the control group (ORR = 2.29 [95% CI 1.58 3.32], P &lt;0.0001). PFS significantly improved compared with conventional treatment (HR = 0.69 [95% CI 0.56, 0.85], P = 0.0005), which was statistically significant. OS also improved but did not statistically significant (HR = 0.80 [95% CI 0.61, 1.05], P = 0.11). PD-1/PD-L1 combined with CTLA-4 inhibitors had a higher incidence of adverse reactions than conventional treatment (OR = 1.72 [95% CI 0.59, 5.09], P = 0.33), but the incidence of grade≥3 AEs was lower than the control group (OR = 0.96 [95% CI 0.64, 1.44], P = 0.85).</p></div><div id="sec-4" class="subsection"><p id="p-5"><strong>Conclusion</strong> Double checkpoint inhibitor PD-1/PD-L1 combined with CTLA-4 antibody has synergistic anti-cancer activity and improved ORR and PFS in lung cancer. Adverse reactions are more common than conventional treatment, but are generally controllable. Therefore, PD-1/PD-L1 combined with CTLA-4 inhibitors provides a beacon for the treatment of advanced lung cancer, which has guiding significance for the treatment selection in the future.</p></div></div><h3>Competing Interest Statement</h3><p id="p-6">The authors have declared no competing interest.</p><h3>Funding Statement</h3><p id="p-7">This research received no specific grant from any funding agency in the public, commercial or not-for-profit sectors.</p><h3>Author Declarations</h3><p id="p-8">All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.</p><p id="p-9">Yes</p><p id="p-10">All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.</p><p id="p-11">Yes</p><p id="p-12">I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).</p><p id="p-13">Yes</p><p id="p-14">I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.</p><p id="p-15">Yes</p><div class="section data-availability" id="sec-19"><h2 class="">Data Availability</h2><p id="p-41">No data are available.</p></div><span class="highwire-journal-article-marker-end"></span></div><span class="related-urls"></span></div></div>  </div>

  
  </div>
<div class="panel-separator"></div><div class="panel-pane pane-biorxiv-copyright" >
  
      
  
  <div class="pane-content">
    <div class="field field-name-field-highwire-copyright field-type-text field-label-inline clearfix"><div class="field-label">Copyright&nbsp;</div><div class="field-items"><div class="field-item even">The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.<span class="license-type"> It is made available under a <a href="http://creativecommons.org/licenses/by-nc-nd/4.0/" class="" data-icon-position="" data-hide-link-title="0">CC-BY-NC-ND 4.0 International license</a>.</span></div></div></div>  </div>

  
  </div>
</div>
  </div>
</div>
</div></div>  </div>

  
  </div>
<div class="panel-separator"></div><div class="panel-pane pane-disqus-comment" >
  
      
  
  <div class="pane-content">
    <div id="disqus_thread"><noscript><p><a href="http://medRxiv.disqus.com/?url=https%3A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.1101%2F2020.01.08.20016915v1" class="" data-icon-position="" data-hide-link-title="0">View the discussion thread.</a></p></noscript></div>  </div>

  
  </div>
<div class="panel-separator"></div><div class="panel-pane pane-highwire-back-to-top" >
  
      
  
  <div class="pane-content">
    <a href="#page" class="back-to-top" data-icon-position="" data-hide-link-title="0"><span class="icon-chevron-up"></span> Back to top</a>  </div>

  
  </div>
</div>
			</div>
		</div>
		
		<div class="sidebar-right-wrapper grid-10 omega">
			<div class="panel-panel panel-region-sidebar-right">
			  <div class="inside"><div class="panel-pane pane-highwire-node-pager" >
  
      
  
  <div class="pane-content">
    <div class="pager highwire-pager pager-mini clearfix highwire-node-pager highwire-article-pager"><span class="pager-prev"><a href="/content/10.1101/2020.01.08.20016949v1" title="Assessment of Machine Learning Algorithms for Prediction of Breast Cancer Malignancy Based on Mammogram Numeric Data" rel="prev" class="pager-link-prev link-icon"><span class="icon-circle-arrow-left"></span> <span class="title">Previous</span></a></span><span class="pager-next"><a href="/content/10.1101/19000380v1" title="Disease overarching mechanisms that explain and predict outcome of patients with high cardiovascular risk: rationale and design of the Berlin Long-term Observation of Vascular Events (BeLOVE) study" rel="next" class="pager-link-next link-icon-right link-icon"><span class="title">Next</span> <span class="icon-circle-arrow-right"></span></a></span></div>  </div>

  
  </div>
<div class="panel-separator"></div><div class="panel-pane pane-custom pane-1" >
  
      
  
  <div class="pane-content">
    Posted&nbsp;January 10, 2020.  </div>

  
  </div>
<div class="panel-separator"></div><div class="panel-pane pane-panels-mini pane-biorxiv-art-tools" >
  
      
  
  <div class="pane-content">
    <div id="mini-panel-biorxiv_art_tools" class="highwire-2col-stacked panel-display">
	  
  <div class="panel-row-wrapper clearfix">
		<div class="content-left-wrapper content-column">
          <div class="panel-panel panel-region-content-left">
            <div class="inside"><div class="panel-pane pane-highwire-variant-link" >
  
      
  
  <div class="pane-content">
    <a href="/content/10.1101/2020.01.08.20016915v1.full.pdf" target="_self" class="article-dl-pdf-link link-icon"><span class="icon-external-link-sign"></span> <span class="title">Download PDF</span></a>  </div>

  
  </div>
<div class="panel-separator"></div><div class="panel-pane pane-biorxiv-supplementary-fragment" >
  
      
  
  <div class="pane-content">
    <p><a href="/content/10.1101/2020.01.08.20016915v1.supplementary-material"><i class="icon-file"></i>Supplementary Material </a></p>  </div>

  
  </div>
<div class="panel-separator"></div><div class="panel-pane pane-highwire-variant-link" >
  
      
  
  <div class="pane-content">
    <a href="/content/early/2020/01/10/2020.01.08.20016915.external-links" target="_self" class="link-icon"><span class="icon-file"></span> <span class="title">Data/Code</span></a>  </div>

  
  </div>
</div>
          </div>
        </div>
        
        <div class="content-right-wrapper content-column">
          <div class="panel-panel panel-region-content-right">
            <div class="inside"><div class="panel-pane pane-minipanel-dialog-link pane-biorxiv-art-email" >
  
      
  
  <div class="pane-content">
    <div class='minipanel-dialog-wrapper'><div class='minipanel-dialog-link-link'><a href="/" oncontextmenu="javascript: return false;" class="minipanel-dialog-link-trigger" title="Email this Article" data-icon-position="" data-hide-link-title="0"><i class = 'icon-envelope'></i> Email</a></div><div class='minipanel-dialog-link-mini' style='display:none'><div class="panel-display panel-1col clearfix" id="mini-panel-biorxiv_art_email">
  <div class="panel-panel panel-col">
    <div><div class="panel-pane pane-block pane-forward-form pane-forward" >
  
      
  
  <div class="pane-content">
    <form action="/content/10.1101/2020.01.08.20016915v1" method="post" id="forward-form" accept-charset="UTF-8"><div><div id="edit-instructions" class="form-item form-item-label-before form-type-item">
 <p>Thank you for your interest in spreading the word about medRxiv.</p><p>NOTE: Your email address is requested solely to identify you as the sender of this article.</p>
</div>
<div class="form-item form-item-label-before form-type-textfield form-item-email">
  <label for="edit-email">Your Email <span class="form-required" title="This field is required.">*</span></label>
 <input type="text" id="edit-email" name="email" value="" size="58" maxlength="256" class="form-text required" />
</div>
<div class="form-item form-item-label-before form-type-textfield form-item-name">
  <label for="edit-name">Your Name <span class="form-required" title="This field is required.">*</span></label>
 <input type="text" id="edit-name" name="name" value="" size="58" maxlength="256" class="form-text required" />
</div>
<div class="form-item form-item-label-before form-type-textarea form-item-recipients">
  <label for="edit-recipients">Send To <span class="form-required" title="This field is required.">*</span></label>
 <div class="form-textarea-wrapper resizable"><textarea id="edit-recipients" name="recipients" cols="50" rows="5" class="form-textarea required"></textarea></div>
<div class="description">Enter multiple addresses on separate lines or separate them with commas.</div>
</div>
<div id="edit-page" class="form-item form-item-label-before form-type-item">
  <label for="edit-page">You are going to email the following </label>
 <a href="/content/10.1101/2020.01.08.20016915v1" class="active" data-icon-position="" data-hide-link-title="0">Efficacy and Safety of PD-1/PD-L1 plus CTLA-4 antibodies +/− Other Therapies in Lung Cancer: A Systematic Review and Meta-Analysis</a>
</div>
<div id="edit-subject" class="form-item form-item-label-before form-type-item">
  <label for="edit-subject">Message Subject </label>
 (Your Name) has forwarded a page to you from medRxiv
</div>
<div id="edit-body" class="form-item form-item-label-before form-type-item">
  <label for="edit-body">Message Body </label>
 (Your Name) thought you would like to see this page from the medRxiv website.
</div>
<div class="form-item form-item-label-before form-type-textarea form-item-message">
  <label for="edit-message--2">Your Personal Message </label>
 <div class="form-textarea-wrapper resizable"><textarea id="edit-message--2" name="message" cols="50" rows="10" class="form-textarea"></textarea></div>
</div>
<input type="hidden" name="path" value="node/71120" />
<input type="hidden" name="path_cid" value="" />
<input type="hidden" name="forward_footer" value=" " />
<input type="hidden" name="form_build_id" value="form-q1y98dTQSCDJgzxR9g-hyxm70SCXwhDWcNLUcgxx56g" />
<input type="hidden" name="form_id" value="forward_form" />
<fieldset class="captcha form-wrapper"><legend><span class="fieldset-legend">CAPTCHA</span></legend><div class="fieldset-wrapper"><div class="fieldset-description">This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.</div><input type="hidden" name="captcha_sid" value="157710309" />
<input type="hidden" name="captcha_token" value="1f8af294b906e77a715c588f93348952" />
<input type="hidden" name="captcha_response" value="Google no captcha" />
<div class="g-recaptcha" data-sitekey="6LfnJVIUAAAAAE-bUOMg0MJGki4lqSvDmhJp19fN" data-theme="light" data-type="image"></div></div></fieldset>
<div class="form-actions form-wrapper" id="edit-actions"><input type="submit" id="edit-submit" name="op" value="Send Message" class="form-submit" /></div></div></form>  </div>

  
  </div>
</div>
  </div>
</div>
</div></div>  </div>

  
  </div>
<div class="panel-separator"></div><div class="panel-pane pane-highwire-share-link highwire_clipboard_link_ajax"  id="shareit">
  
      
  
  <div class="pane-content">
    <a href="/" class="link-icon"><span class="icon-share-alt"></span> <span class="title">Share</span></a>  </div>

  
  </div>
<div class="panel-separator"></div><div class="panel-pane pane-panels-mini pane-biorxiv-share highwire_clipboard_form_ajax_shareit" >
  
      
  
  <div class="pane-content">
    
<div class="panel-display omega-12-onecol" id="mini-panel-biorxiv_share">

		  <div class="panel-panel grid-12 panel-region-preface">
		  <div class="inside"><div class="panel-pane pane-highwire-article-citation" >
  
      
  
  <div class="pane-content">
    <div class="highwire-article-citation highwire-citation-type-highwire-article node71120--3" data-node-nid="71120" id="node71120--41550028126" data-pisa="medrxiv;2020.01.08.20016915v1" data-pisa-master="medrxiv;2020.01.08.20016915" data-seqnum="71120" data-apath="/medrxiv/early/2020/01/10/2020.01.08.20016915.atom"><div  class="highwire-cite highwire-cite-highwire-article highwire-citation-biorxiv-article-pap-list clearfix" >

      <div class="highwire-cite-title" >
      <div class="highwire-cite-title">Efficacy and Safety of PD-1/PD-L1 plus CTLA-4 antibodies +/− Other Therapies in Lung Cancer: A Systematic Review and Meta-Analysis</div>    </div>
  
      <div  class="highwire-cite-authors" ><span  class="highwire-citation-authors"><span class="highwire-citation-author first" data-delta="0"><span class="nlm-given-names">Xiang</span> <span class="nlm-surname">Shen</span></span>, <span class="highwire-citation-author" data-delta="1"><span class="nlm-given-names">Hua</span> <span class="nlm-surname">Xiao</span></span>, <span class="highwire-citation-author" data-delta="2"><span class="nlm-given-names">Shangke</span> <span class="nlm-surname">Huang</span></span>, <span class="highwire-citation-author" data-delta="3"><span class="nlm-given-names">Jiexing</span> <span class="nlm-surname">Liu</span></span>, <span class="highwire-citation-author" data-delta="4"><span class="nlm-given-names">Zhuolan</span> <span class="nlm-surname">Ran</span></span>, <span class="highwire-citation-author" data-delta="5"><span class="nlm-given-names">Bin</span> <span class="nlm-surname">Xiong</span></span></span></div>
  
      <div  class="highwire-cite-metadata" ><span  class="highwire-cite-metadata-journal highwire-cite-metadata">medRxiv </span><span  class="highwire-cite-metadata-pages highwire-cite-metadata">2020.01.08.20016915; </span><span  class="highwire-cite-metadata-doi highwire-cite-metadata"><span class="doi_label">doi:</span> https://doi.org/10.1101/2020.01.08.20016915 </span></div>
  
  
  </div>
</div>  </div>

  
  </div>
</div>
	  </div>
	
  <div class="panel-panel grid-12 panel-region-content">
  	<div class="inside"><div class="panel-pane pane-highwire-article-clipboard-copy" >
  
      
  
  <div class="pane-content">
    <div class = "clipboard-copy">
  <span class="label-url">
    <label for="dynamic">Share This Article:</label>
  </span>
  <span class="input-text-url">
    <input type="text" id="dynamic" value="https://www.medrxiv.org/content/10.1101/2020.01.08.20016915v1" size="50"/>
  </span>
  <span class="copy-button button">
    <button id="copy-dynamic" class="clipboardjs-button" data-clipboard-target="#dynamic" data-clipboard-alert-style="tooltip" data-clipboard-alert-text="Copied!">Copy</button>
  </span>
</div>
  </div>

  
  </div>
</div>
  </div>
	
		  <div class="panel-panel grid-12 panel-region-postscript">
	    <div class="inside"><div class="panel-pane pane-service-links" >
  
      
  
  <div class="pane-content">
    <div class="service-links"><a href="http://digg.com/submit?phase=2&amp;url=https%3A//www.medrxiv.org/content/10.1101/2020.01.08.20016915v1&amp;title=Efficacy%20and%20Safety%20of%20PD-1/PD-L1%20plus%20CTLA-4%20antibodies%20%2B/%E2%88%92%20Other%20Therapies%20in%20Lung%20Cancer%3A%20A%20Systematic%20Review%20and%20Meta-Analysis" id="digg" title="Digg this post on digg.com" class="service-links-digg" rel="nofollow" data-icon-position="" data-hide-link-title="0"><img src="https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/digg.png" alt="Digg logo" /></a> <a href="http://reddit.com/submit?url=https%3A//www.medrxiv.org/content/10.1101/2020.01.08.20016915v1&amp;title=Efficacy%20and%20Safety%20of%20PD-1/PD-L1%20plus%20CTLA-4%20antibodies%20%2B/%E2%88%92%20Other%20Therapies%20in%20Lung%20Cancer%3A%20A%20Systematic%20Review%20and%20Meta-Analysis" id="reddit" title="Submit this post on reddit.com" class="service-links-reddit" rel="nofollow" data-icon-position="" data-hide-link-title="0"><img src="https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/reddit.png" alt="Reddit logo" /></a> <a href="http://twitter.com/share?url=https%3A//www.medrxiv.org/content/10.1101/2020.01.08.20016915v1&amp;text=Efficacy%20and%20Safety%20of%20PD-1/PD-L1%20plus%20CTLA-4%20antibodies%20%2B/%E2%88%92%20Other%20Therapies%20in%20Lung%20Cancer%3A%20A%20Systematic%20Review%20and%20Meta-Analysis" id="twitter" title="Share this on Twitter" class="service-links-twitter" rel="nofollow" data-icon-position="" data-hide-link-title="0"><img src="https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/twitter.png" alt="Twitter logo" /></a> <a href="http://www.citeulike.org/posturl?url=https%3A//www.medrxiv.org/content/10.1101/2020.01.08.20016915v1&amp;title=Efficacy%20and%20Safety%20of%20PD-1/PD-L1%20plus%20CTLA-4%20antibodies%20%2B/%E2%88%92%20Other%20Therapies%20in%20Lung%20Cancer%3A%20A%20Systematic%20Review%20and%20Meta-Analysis" id="citeulike" title="Share on CiteULike" class="service-links-citeulike" rel="nofollow" data-icon-position="" data-hide-link-title="0"><img src="https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/citeyoulike.png" alt="CiteULike logo" /></a> <a href="http://www.facebook.com/sharer.php?u=https%3A//www.medrxiv.org/content/10.1101/2020.01.08.20016915v1&amp;t=Efficacy%20and%20Safety%20of%20PD-1/PD-L1%20plus%20CTLA-4%20antibodies%20%2B/%E2%88%92%20Other%20Therapies%20in%20Lung%20Cancer%3A%20A%20Systematic%20Review%20and%20Meta-Analysis" id="facebook" title="Share on Facebook" class="service-links-facebook" rel="nofollow" data-icon-position="" data-hide-link-title="0"><img src="https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/fb-blue.png" alt="Facebook logo" /></a> <a href="http://www.google.com/bookmarks/mark?op=add&amp;bkmk=https%3A//www.medrxiv.org/content/10.1101/2020.01.08.20016915v1&amp;title=Efficacy%20and%20Safety%20of%20PD-1/PD-L1%20plus%20CTLA-4%20antibodies%20%2B/%E2%88%92%20Other%20Therapies%20in%20Lung%20Cancer%3A%20A%20Systematic%20Review%20and%20Meta-Analysis" id="google" title="Bookmark this post on Google" class="service-links-google" rel="nofollow" data-icon-position="" data-hide-link-title="0"><img src="https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/google-32.png" alt="Google logo" /></a> <a href="http://www.mendeley.com/import/?url=https%3A//www.medrxiv.org/content/10.1101/2020.01.08.20016915v1&amp;title=Efficacy%20and%20Safety%20of%20PD-1/PD-L1%20plus%20CTLA-4%20antibodies%20%2B/%E2%88%92%20Other%20Therapies%20in%20Lung%20Cancer%3A%20A%20Systematic%20Review%20and%20Meta-Analysis" id="mendeley" title="Share on Mendeley" class="service-links-mendeley" rel="nofollow" data-icon-position="" data-hide-link-title="0"><img src="https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/mendeley.png" alt="Mendeley logo" /></a></div>  </div>

  
  </div>
</div>
	  </div>
	
</div>
  </div>

  
  </div>
<div class="panel-separator"></div><div class="panel-pane pane-minipanel-dialog-link pane-biorxiv-cite-tool" >
  
      
  
  <div class="pane-content">
    <div class='minipanel-dialog-wrapper'><div class='minipanel-dialog-link-link'><a href="/" oncontextmenu="javascript: return false;" class="minipanel-dialog-link-trigger link-icon" title="Citation Tools"><span class="icon-globe"></span> <span class="title">Citation Tools</span></a></div><div class='minipanel-dialog-link-mini' style='display:none'><div class="panel-display panel-1col clearfix" id="mini-panel-biorxiv_cite_tool">
  <div class="panel-panel panel-col">
    <div><div class="panel-pane pane-highwire-citation-export" >
  
      
  
  <div class="pane-content">
    <div class="highwire-citation-export">  
  <div class="highwire-citation-info">
      <div class="highwire-article-citation highwire-citation-type-highwire-article node71120--5" data-node-nid="71120" id="node71120--6942278480" data-pisa="medrxiv;2020.01.08.20016915v1" data-pisa-master="medrxiv;2020.01.08.20016915" data-seqnum="71120" data-apath="/medrxiv/early/2020/01/10/2020.01.08.20016915.atom"><div  class="highwire-cite highwire-cite-highwire-article highwire-citation-biorxiv-article-pap-list clearfix" >

      <div class="highwire-cite-title" >
      <div class="highwire-cite-title">Efficacy and Safety of PD-1/PD-L1 plus CTLA-4 antibodies +/− Other Therapies in Lung Cancer: A Systematic Review and Meta-Analysis</div>    </div>
  
      <div  class="highwire-cite-authors" ><span  class="highwire-citation-authors"><span class="highwire-citation-author first" data-delta="0"><span class="nlm-given-names">Xiang</span> <span class="nlm-surname">Shen</span></span>, <span class="highwire-citation-author" data-delta="1"><span class="nlm-given-names">Hua</span> <span class="nlm-surname">Xiao</span></span>, <span class="highwire-citation-author" data-delta="2"><span class="nlm-given-names">Shangke</span> <span class="nlm-surname">Huang</span></span>, <span class="highwire-citation-author" data-delta="3"><span class="nlm-given-names">Jiexing</span> <span class="nlm-surname">Liu</span></span>, <span class="highwire-citation-author" data-delta="4"><span class="nlm-given-names">Zhuolan</span> <span class="nlm-surname">Ran</span></span>, <span class="highwire-citation-author" data-delta="5"><span class="nlm-given-names">Bin</span> <span class="nlm-surname">Xiong</span></span></span></div>
  
      <div  class="highwire-cite-metadata" ><span  class="highwire-cite-metadata-journal highwire-cite-metadata">medRxiv </span><span  class="highwire-cite-metadata-pages highwire-cite-metadata">2020.01.08.20016915; </span><span  class="highwire-cite-metadata-doi highwire-cite-metadata"><span class="doi_label">doi:</span> https://doi.org/10.1101/2020.01.08.20016915 </span></div>
  
  
  </div>
</div>  </div>
  <div class="highwire-citation-formats">
  	      <h2>Citation Manager Formats</h2>
        <div class="highwire-citation-formats-links">
      <span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.spage&amp;rft.epage&amp;rft.atitle=Efficacy%20and%20Safety%20of%20PD-1/PD-L1%20plus%20CTLA-4%20antibodies%20%2B/%E2%88%92%20Other%20Therapies%20in%20Lung%20Cancer%3A%20A%20Systematic%20Review%20and%20Meta-Analysis&amp;rft.volume&amp;rft.issue&amp;rft.date=2020-01-01%2000%3A00%3A00&amp;rft.stitle&amp;rft.jtitle=medRxiv&amp;rft.au=Shen%2C+Xiang&amp;rft.au=Xiao%2C+Hua&amp;rft.au=Huang%2C+Shangke&amp;rft.au=Liu%2C+Jiexing&amp;rft.au=Ran%2C+Zhuolan&amp;rft.au=Xiong%2C+Bin"></span><ul class="hw-citation-links inline button button-alt button-grid clearfix"><li class="bibtext first"><a href="/highwire/citation/71120/bibtext" class="hw-download-citation-link" data-icon-position="" data-hide-link-title="0">BibTeX</a></li><li class="bookends"><a href="/highwire/citation/71120/bookends" class="hw-download-citation-link" data-icon-position="" data-hide-link-title="0">Bookends</a></li><li class="easybib"><a href="/highwire/citation/71120/easybib" class="hw-download-citation-link" data-icon-position="" data-hide-link-title="0">EasyBib</a></li><li class="endnote-tagged"><a href="/highwire/citation/71120/endnote-tagged" class="hw-download-citation-link" data-icon-position="" data-hide-link-title="0">EndNote (tagged)</a></li><li class="endnote-8-xml"><a href="/highwire/citation/71120/endnote-8-xml" class="hw-download-citation-link" data-icon-position="" data-hide-link-title="0">EndNote 8 (xml)</a></li><li class="medlars"><a href="/highwire/citation/71120/medlars" class="hw-download-citation-link" data-icon-position="" data-hide-link-title="0">Medlars</a></li><li class="mendeley"><a href="/highwire/citation/71120/mendeley" class="hw-download-citation-link" data-icon-position="" data-hide-link-title="0">Mendeley</a></li><li class="papers"><a href="/highwire/citation/71120/papers" class="hw-download-citation-link" data-icon-position="" data-hide-link-title="0">Papers</a></li><li class="refworks-tagged"><a href="/highwire/citation/71120/refworks-tagged" class="hw-download-citation-link" data-icon-position="" data-hide-link-title="0">RefWorks Tagged</a></li><li class="reference-manager"><a href="/highwire/citation/71120/reference-manager" class="hw-download-citation-link" data-icon-position="" data-hide-link-title="0">Ref Manager</a></li><li class="ris"><a href="/highwire/citation/71120/ris" class="hw-download-citation-link" data-icon-position="" data-hide-link-title="0">RIS</a></li><li class="zotero last"><a href="/highwire/citation/71120/zotero" class="hw-download-citation-link" data-icon-position="" data-hide-link-title="0">Zotero</a></li></ul>    </div>
  </div>
</div>
  </div>

  
  </div>
</div>
  </div>
</div>
</div></div>  </div>

  
  </div>
</div>
          </div>
        </div>
	</div> <!-- /.panel-row-wrapper -->	
	
	</div>

  </div>

  
  </div>
<div class="panel-separator"></div><div class="panel-pane pane-service-links" >
  
      
  
  <div class="pane-content">
    <div class="service-links"><div class="item-list"><ul><li class="first"><a href="http://twitter.com/share?url=https%3A//www.medrxiv.org/content/10.1101/2020.01.08.20016915v1&amp;count=horizontal&amp;via=&amp;text=Efficacy%20and%20Safety%20of%20PD-1/PD-L1%20plus%20CTLA-4%20antibodies%20%2B/%E2%88%92%20Other%20Therapies%20in%20Lung%20Cancer%3A%20A%20Systematic%20Review%20and%20Meta-Analysis&amp;counturl=https%3A//www.medrxiv.org/content/10.1101/2020.01.08.20016915v1" class="twitter-share-button service-links-twitter-widget" id="twitter_widget" title="Tweet This" rel="nofollow" data-icon-position="" data-hide-link-title="0"><span class="element-invisible">Tweet Widget</span></a></li><li><a href="http://www.facebook.com/plugins/like.php?href=https%3A//www.medrxiv.org/content/10.1101/2020.01.08.20016915v1&amp;layout=button_count&amp;show_faces=false&amp;action=like&amp;colorscheme=light&amp;width=100&amp;height=21&amp;font=&amp;locale=" id="facebook_like" title="I Like it" class="service-links-facebook-like" rel="nofollow" data-icon-position="" data-hide-link-title="0"><span class="element-invisible">Facebook Like</span></a></li><li class="last"><a href="https://www.medrxiv.org/content/10.1101/2020.01.08.20016915v1" id="google_plus_one" title="Plus it" class="service-links-google-plus-one" rel="nofollow" data-icon-position="" data-hide-link-title="0"><span class="element-invisible">Google Plus One</span></a></li></ul></div></div>  </div>

  
  </div>
<div class="panel-separator"></div><div class="panel-pane pane-highwire-article-collections" >
  
        <h2 class="pane-title">Subject Area</h2>
    
  
  <div class="pane-content">
    <div class="highwire-list-wrapper highwire-article-collections"><div class="highwire-list"><ul class="highwire-article-collection-term-list"><li class="first last odd"><span class="highwire-article-collection-term"><a href="/collection/oncology" class="highlight" data-icon-position="" data-hide-link-title="0">Oncology<i class="icon-caret-right"></i>
</a></span></li></ul></div></div>  </div>

  
  </div>
<div class="panel-separator"></div><div class="panel-pane pane-panels-mini pane-biorxiv-subject-collections block-style-col2" >
  
      
  
  <div class="pane-content">
    <div class="panel-flexible panels-flexible-8 clearfix" id="mini-panel-biorxiv_subject_collections">
<div class="panel-flexible-inside panels-flexible-8-inside">
<div class="panels-flexible-region panels-flexible-region-8-center panels-flexible-region-first panels-flexible-region-last">
  <div class="inside panels-flexible-region-inside panels-flexible-region-8-center-inside panels-flexible-region-inside-first panels-flexible-region-inside-last">
<div class="panel-pane pane-snippet" >
  
      
  
  <div class="pane-content">
    <div class="snippet biorxiv-subject-areas-table-title" id="biorxiv-subject-areas-table-title">
  
      
  <div class="snippet-content">
    <b>Subject Areas</b>  </div>

</div>
  </div>

  
  </div>
<div class="panel-separator"></div><div class="panel-pane pane-snippet" >
  
      
  
  <div class="pane-content">
    <div class="snippet biorxiv-subject-areas-view-papers" id="biorxiv-subject-areas-view-papers">
  
      
  <div class="snippet-content">
    <a href="/content/early/recent"><strong>All Articles</strong></a>  </div>

</div>
  </div>

  
  </div>
<div class="panel-separator"></div><div class="panel-pane pane-highwire-subject-collections" >
  
      
  
  <div class="pane-content">
    <ul id="collection" class="collection highwire-list-expand"><li class="outer collection depth-2  child first"><div class = "data-wrapper"><a href="/collection/addiction-medicine" class="" data-icon-position="" data-hide-link-title="0">Addiction Medicine</a> <span class = "article-count">(111)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/allergy-and-immunology" class="" data-icon-position="" data-hide-link-title="0">Allergy and Immunology</a> <span class = "article-count">(299)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/anesthesia" class="" data-icon-position="" data-hide-link-title="0">Anesthesia</a> <span class = "article-count">(75)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/cardiovascular-medicine" class="" data-icon-position="" data-hide-link-title="0">Cardiovascular Medicine</a> <span class = "article-count">(665)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/dentistry-and-oral-medicine" class="" data-icon-position="" data-hide-link-title="0">Dentistry and Oral Medicine</a> <span class = "article-count">(121)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/dermatology" class="" data-icon-position="" data-hide-link-title="0">Dermatology</a> <span class = "article-count">(77)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/emergency-medicine" class="" data-icon-position="" data-hide-link-title="0">Emergency Medicine</a> <span class = "article-count">(216)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/endocrinology-including-diabetes-mellitus-and-metabolic-disease" class="" data-icon-position="" data-hide-link-title="0">Endocrinology (including Diabetes Mellitus and Metabolic Disease)</a> <span class = "article-count">(299)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/epidemiology" class="" data-icon-position="" data-hide-link-title="0">Epidemiology</a> <span class = "article-count">(7268)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/forensic-medicine" class="" data-icon-position="" data-hide-link-title="0">Forensic Medicine</a> <span class = "article-count">(4)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/gastroenterology" class="" data-icon-position="" data-hide-link-title="0">Gastroenterology</a> <span class = "article-count">(306)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/genetic-and-genomic-medicine" class="" data-icon-position="" data-hide-link-title="0">Genetic and Genomic Medicine</a> <span class = "article-count">(1295)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/geriatric-medicine" class="" data-icon-position="" data-hide-link-title="0">Geriatric Medicine</a> <span class = "article-count">(126)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/health-economics" class="" data-icon-position="" data-hide-link-title="0">Health Economics</a> <span class = "article-count">(308)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/health-informatics" class="" data-icon-position="" data-hide-link-title="0">Health Informatics</a> <span class = "article-count">(1004)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/health-policy" class="" data-icon-position="" data-hide-link-title="0">Health Policy</a> <span class = "article-count">(526)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/health-systems-and-quality-improvement" class="" data-icon-position="" data-hide-link-title="0">Health Systems and Quality Improvement</a> <span class = "article-count">(359)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/hematology" class="" data-icon-position="" data-hide-link-title="0">Hematology</a> <span class = "article-count">(151)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/hiv-aids" class="" data-icon-position="" data-hide-link-title="0">HIV/AIDS</a> <span class = "article-count">(287)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/infectious_diseases" class="" data-icon-position="" data-hide-link-title="0">Infectious Diseases (except HIV/AIDS)</a> <span class = "article-count">(8512)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/intensive-care-and-critical-care-medicine" class="" data-icon-position="" data-hide-link-title="0">Intensive Care and Critical Care Medicine</a> <span class = "article-count">(483)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/medical-education" class="" data-icon-position="" data-hide-link-title="0">Medical Education</a> <span class = "article-count">(160)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/medical-ethics" class="" data-icon-position="" data-hide-link-title="0">Medical Ethics</a> <span class = "article-count">(40)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/nephrology" class="" data-icon-position="" data-hide-link-title="0">Nephrology</a> <span class = "article-count">(153)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/neurology" class="" data-icon-position="" data-hide-link-title="0">Neurology</a> <span class = "article-count">(1239)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/nursing" class="" data-icon-position="" data-hide-link-title="0">Nursing</a> <span class = "article-count">(63)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/nutrition" class="" data-icon-position="" data-hide-link-title="0">Nutrition</a> <span class = "article-count">(200)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/obstetrics-and-gynecology" class="" data-icon-position="" data-hide-link-title="0">Obstetrics and Gynecology</a> <span class = "article-count">(255)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/occupational-and-environmental-health" class="" data-icon-position="" data-hide-link-title="0">Occupational and Environmental Health</a> <span class = "article-count">(368)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/oncology" class="" data-icon-position="" data-hide-link-title="0">Oncology</a> <span class = "article-count">(702)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/ophthalmology" class="" data-icon-position="" data-hide-link-title="0">Ophthalmology</a> <span class = "article-count">(217)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/orthopedics" class="" data-icon-position="" data-hide-link-title="0">Orthopedics</a> <span class = "article-count">(70)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/otolaryngology" class="" data-icon-position="" data-hide-link-title="0">Otolaryngology</a> <span class = "article-count">(139)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/pain-medicine" class="" data-icon-position="" data-hide-link-title="0">Pain Medicine</a> <span class = "article-count">(73)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/palliative-medicine" class="" data-icon-position="" data-hide-link-title="0">Palliative Medicine</a> <span class = "article-count">(30)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/pathology" class="" data-icon-position="" data-hide-link-title="0">Pathology</a> <span class = "article-count">(195)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/pediatrics" class="" data-icon-position="" data-hide-link-title="0">Pediatrics</a> <span class = "article-count">(410)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/pharmacology-and-therapeutics" class="" data-icon-position="" data-hide-link-title="0">Pharmacology and Therapeutics</a> <span class = "article-count">(195)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/primary-care-research" class="" data-icon-position="" data-hide-link-title="0">Primary Care Research</a> <span class = "article-count">(158)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/psychiatry-and-clinical-psychology" class="" data-icon-position="" data-hide-link-title="0">Psychiatry and Clinical Psychology</a> <span class = "article-count">(1369)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/public-and-global-health" class="" data-icon-position="" data-hide-link-title="0">Public and Global Health</a> <span class = "article-count">(3057)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/radiology-and-imaging" class="" data-icon-position="" data-hide-link-title="0">Radiology and Imaging</a> <span class = "article-count">(509)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/rehabilitation-medicine-and-physical-therapy" class="" data-icon-position="" data-hide-link-title="0">Rehabilitation Medicine and Physical Therapy</a> <span class = "article-count">(244)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/respiratory-medicine" class="" data-icon-position="" data-hide-link-title="0">Respiratory Medicine</a> <span class = "article-count">(415)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/rheumatology" class="" data-icon-position="" data-hide-link-title="0">Rheumatology</a> <span class = "article-count">(158)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/sexual-and-reproductive-health" class="" data-icon-position="" data-hide-link-title="0">Sexual and Reproductive Health</a> <span class = "article-count">(118)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/sports-medicine" class="" data-icon-position="" data-hide-link-title="0">Sports Medicine</a> <span class = "article-count">(115)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/surgery" class="" data-icon-position="" data-hide-link-title="0">Surgery</a> <span class = "article-count">(153)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/toxicology" class="" data-icon-position="" data-hide-link-title="0">Toxicology</a> <span class = "article-count">(32)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/transplantation" class="" data-icon-position="" data-hide-link-title="0">Transplantation</a> <span class = "article-count">(67)</span></div></li>
<li class="outer collection depth-2  child last"><div class = "data-wrapper"><a href="/collection/urology" class="" data-icon-position="" data-hide-link-title="0">Urology</a> <span class = "article-count">(51)</span></div></li>
</ul>  </div>

  
  </div>
  </div>
</div>
</div>
</div>
  </div>

  
  </div>
</div>
			</div>
		</div>
	
	</div> <!-- /.panel-row-wrapper -->	
	
	</div>

    </div>
  </div>
</div>      </div>
</div>  </div>
</section>    
  
  </div>    <div class="region region-page-bottom" id="region-page-bottom">
  <div class="region-inner region-page-bottom-inner">
      </div>
</div><script type="text/javascript" src="https://www.medrxiv.org/sites/default/files/advagg_js/js__Vh5BcRYb6VtLoN3uam6O4DIKltYUVMjVDWtakoysPq0__Wed8jsPTirEozek7dWSCS8970Cp7a9xKKgFk6FPuSVM__OWu9jWxbqz5eMqeTDc4xZhOzPlgoEqGh5PmxOqlf8ZY.js"></script>
<script type="text/javascript" src="https://d33xdlntwy0kbs.cloudfront.net/cshl_custom_medrxiv.js"></script>
<script type="text/javascript" src="https://www.medrxiv.org/sites/default/files/advagg_js/js__BmqjBnkz3MgYCAoc25s1lDRMEjLhC3mEPVonUFIHi08__Unwv5-ZIuHBfFwytsjEx1niBVJ7n1T4lPws7VrkHXM4__OWu9jWxbqz5eMqeTDc4xZhOzPlgoEqGh5PmxOqlf8ZY.js"></script>
<script type="text/javascript">
<!--//--><![CDATA[//><!--
function euCookieComplianceLoadScripts() {}
//--><!]]>
</script>
<script type="text/javascript">
<!--//--><![CDATA[//><!--
var eu_cookie_compliance_cookie_name = "";
//--><!]]>
</script>
  </body>
</html>
